Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.725209419818841e-44,32.77800829875519,3277.755629703563,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.0302391338012683e-41,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.665161558836807e-36,18.837245954083553,1525.744759703064,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6B1', 'COX7A2L', 'SCO1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A14', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV3', 'NDUFV2', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'DMAC2L', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",1.81625652478303e-33,0,0,71
3,Oxidative phosphorylation WP623,8.858650002685418e-21,17.219389653889095,795.0690286059872,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV3', 'NDUFV2', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'DMAC2L', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.6093214171545175e-18,0,0,41
4,Nonalcoholic fatty liver disease WP4396,2.548138210514923e-15,4.283321207285017,143.93421332160423,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'COX6A1', 'COX7C', 'BBC3', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6B1', 'COX7A2L', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'ATF4', 'CEBPA', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'CDC42', 'MAPK9', 'NDUFV3', 'NDUFV2', 'NDUFV1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'SMAD7', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",3.4718383118265827e-13,0,0,65
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.0192417424052874e-13,8.896761321455086,266.14258690374714,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'DMAC2', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM70', 'NDUFV3', 'NDUFV2', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'ACAD9', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'TMEM126B']",1.1109734992217633e-11,0,0,34
6,Mitochondrial CIV Assembly WP4922,1.7860248133904977e-09,9.174796747967479,184.81043984627283,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'COX11', 'COX14', 'SMIM20']",1.6223058721630352e-07,0,0,22
7,Cellular Proteostasis WP4918,5.3960456615677206e-05,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.00420120697936344,0,0,6
8,Base Excision Repair WP4752,0.0006653349502324882,3.636376197494473,26.600891740361472,"['MBD4', 'FEN1', 'LIG1', 'PARP1', 'PARP2', 'LIG3', 'HMGB1', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3']",0.04515592731938557,0,0,14
9,Photodynamic therapy-induced unfolded protein response WP3613,0.0007456942126137067,4.154270986745214,29.915715227650562,"['NARS', 'XBP1', 'WARS', 'HSPA5', 'DDIT3', 'DNAJB11', 'CALR', 'PDIA6', 'HSP90B1', 'BBC3', 'EIF2A', 'ATF4']",0.04515592731938557,0,0,12
10,Pyrimidine metabolism WP4022,0.00092638291757242,2.2481673454276194,15.701701836501094,"['POLD4', 'ZNRD1', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR2I', 'POLR2J', 'POLR2K', 'POLR2L', 'DUT', 'RRM2', 'POLR3GL', 'NME2', 'NME3', 'NME1', 'DCTD', 'POLE4', 'POLR3D', 'POLE3', 'POLR3F', 'POLR1E', 'POLR3H', 'DCTPP1', 'POLR3K']",0.047651408740761146,0,0,27
11,Proteasome Degradation WP183,0.0009617715525658213,2.5693843847106628,17.84882885417143,"['PSMD10', 'UBE2B', 'H2AFZ', 'PSMD13', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMA1', 'PSMB2', 'UBB', 'PSMA2', 'PSMB3', 'PSME3', 'PSMC1', 'UBC', 'PSME1', 'PSME2']",0.047651408740761146,0,0,21
12,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0018930735466042637,1.4462487158872661,9.067333779019345,"['YWHAE', 'RPL5', 'CTNND1', 'CCDC124', 'ARPC5L', 'SRP54', 'ARRB2', 'HMGB1', 'RPL10A', 'RPL7', 'ACTG1', 'RND1', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'TMSB10', 'ACP1', 'HRAS', 'EIF2A', 'DUSP5', 'MEF2C', 'SSR4', 'TPM3', 'FBXW11', 'PRKCD', 'SSR3', 'RPS6', 'SARS', 'RPL13A', 'PLA2G4A', 'PDIA6', 'RHOA', 'RCN1', 'NCL', 'FSCN1', 'RPL27', 'RPL26', 'PFN1', 'ALDOA', 'SLC25A11', 'PTMA', 'ATF4', 'NAPA', 'LRRC59', 'SET', 'NOTCH4', 'CRIP2', 'TXN', 'NDRG1', 'FUT1', 'CAMKK2', 'CDC42', 'STIP1', 'MAPK9', 'PAK1', 'DHX36', 'AP2S1', 'PGK1', 'CCT7', 'ABCF2', 'ZC3H15', 'DECR1', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'STAT1', 'SIAH2', 'IDH2', 'CDC42BPB', 'DNAJA1', 'TFCP2', 'GIPC1', 'RCAN2', 'CALU', 'NOX4', 'CTNNB1', 'CYCS', 'HYOU1', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'RAB5A', 'EIF3D', 'EIF4G2', 'BCAR1', 'BCL2L1']",0.08287917171834124,0,0,94
13,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.002094617534226409,4.67005332842957,28.806683647606015,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF1']",0.08287917171834124,0,0,9
14,Ciliary landscape WP4352,0.002129006245975738,1.627703353471675,10.013793734669607,"['MYL6B', 'PSMD8', 'PSMD7', 'ARHGDIA', 'TNKS1BP1', 'RAC1', 'SNAP29', 'RAB8A', 'BBS4', 'RAB2A', 'EIF5B', 'NUDC', 'DYNLT1', 'EIPR1', 'DYNLT3', 'ACSL3', 'DYNLL1', 'DYNLL2', 'LZTFL1', 'AFG3L2', 'MYL6', 'TIPRL', 'MCM4', 'MCM6', 'PAFAH1B1', 'ECHS1', 'PSMD13', 'CAMK2A', 'COPS7B', 'COPS7A', 'EXOSC7', 'RMND5B', 'PGRMC2', 'EXOSC4', 'DNPEP', 'SNRPB2', 'DCAF11', 'NDUFA5', 'H3F3A', 'IFT122', 'COX6C', 'LSM4', 'AIMP1', 'COPS4', 'IFT20', 'COPS6', 'IFT22', 'RAB14', 'MFAP1', 'CTNNB1', 'IFT27', 'CALM1', 'COPS8', 'CALM2', 'CLUAP1']",0.08287917171834124,0,0,55
15,Purine metabolism WP4792,0.0026317151313684853,8.296840558412931,49.28422442376338,"['PRPS1', 'DGUOK', 'ATIC', 'HPRT1', 'ADSS', 'APRT']",0.0956189831063883,0,0,6
16,Mitochondrial complex III assembly WP4921,0.003518897432198058,4.742857142857143,26.795281607886718,"['UQCRB', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.11986244378424636,0,0,8
17,Myometrial relaxation and contraction pathways WP289,0.004265875993588445,1.7772137338900311,9.69844680134156,"['YWHAE', 'RGS14', 'YWHAB', 'CAMK2A', 'ARRB2', 'ADCY1', 'ADCY7', 'CRHR1', 'ACTG1', 'RGS4', 'GNG3', 'GNG2', 'YWHAQ', 'GNG7', 'GRK6', 'RGS20', 'YWHAH', 'PRKCG', 'JUN', 'GSTO1', 'IGFBP2', 'PRKCD', 'DGKZ', 'YWHAZ', 'CREB3', 'CACNB3', 'PRKAR1A', 'GNB2', 'GNB1', 'CALM3', 'GNB5', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.13675896567680604,0,0,35
18,Translation Factors WP107,0.004560531255800039,2.337799815498155,12.601480121465416,"['EIF4A2', 'EIF4A1', 'EIF5B', 'EIF1AX', 'EIF2S2', 'EIF2S1', 'EIF1', 'EEF1B2', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EIF3J', 'EIF4H', 'ETF1', 'EIF3F', 'EIF3D', 'EIF4B']",0.1380827519117234,0,0,18
19,Pathogenic Escherichia coli infection WP2272,0.007806752287580073,2.3963679151662935,11.629013321830676,"['ARPC5L', 'ARPC4', 'ARPC5', 'YWHAZ', 'RHOA', 'ACTG1', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'ARPC3', 'NCL', 'CTNNB1', 'ARHGEF2']",0.2239305261437442,0,0,15
20,mRNA Processing WP411,0.008448491613764514,1.6649331352154533,7.948003458796242,"['SF3B5', 'DHX8', 'RNMT', 'SRP54', 'CSTF2T', 'HNRNPR', 'SNU13', 'SNRPD2', 'SNRPD1', 'CLP1', 'CSTF1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3A1', 'SNRPN', 'PRMT2', 'NCBP2', 'LSM2', 'PRPF4', 'LSM7', 'PRPF6', 'HNRNPK', 'PHF5A', 'SNRPG', 'SRSF2', 'SRSF3', 'SNRPE', 'SNRPA1', 'HNRNPH2', 'SNRPF', 'DNAJC8', 'RBMX', 'SNRPA', 'SNRPB']",0.230221396475083,0,0,36
21,Purine metabolism and related disorders WP4224,0.009183576058688615,3.6882352941176473,17.29907237077829,"['PRPS1', 'DGUOK', 'ATIC', 'PPAT', 'HPRT1', 'PFAS', 'ADSS', 'APRT']",0.23833566438025217,0,0,8
22,Nucleotide Excision Repair WP4753,0.01583219661487716,2.1478958272430315,8.904552462344775,"['RFC3', 'LIG1', 'RFC2', 'CETN2', 'RPA1', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'POLE4', 'DDB1', 'POLD4', 'POLD2', 'ERCC2', 'POLE3']",0.3922066888685478,0,0,15
23,Nucleotide metabolism WP404,0.019778974553596253,3.0171122994652406,11.836541264756601,"['PRPS2', 'PRPS1', 'RRM2', 'NME2', 'HPRT1', 'OAZ1', 'ADSS', 'SRM']",0.4686757013786938,0,0,8
24,Urea cycle and metabolism of amino groups WP497,0.02302041601913853,3.2260198456449833,12.166526736333159,"['GAMT', 'GATM', 'ODC1', 'SMS', 'PYCR3', 'ASS1', 'SRM']",0.5227552804346041,0,0,7
25,Calcium Regulation in the Cardiac Cell WP536,0.026342797533123952,1.5470291905320543,5.625865060620873,"['YWHAE', 'RGS14', 'YWHAB', 'CAMK2A', 'ARRB2', 'ADCY1', 'ADCY7', 'RGS4', 'GNG3', 'GNG2', 'YWHAQ', 'GNG7', 'GRK6', 'RGS20', 'YWHAH', 'PRKCG', 'KCNB1', 'PRKCD', 'YWHAZ', 'GNAO1', 'FKBP1A', 'CACNB3', 'PRKAR1A', 'GNB2', 'CAMK4', 'GNB1', 'CALM3', 'CALR', 'GNB5', 'CAMK1', 'CALM1', 'CALM2']",0.5742729862221022,0,0,32
26,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.027466421914994002,2.7654411764705884,9.941183167348875,"['G6PD', 'MDH1', 'PARP1', 'GOT1', 'MDH2', 'HMGA1', 'NMNAT2', 'ELAVL1']",0.5757384593719896,0,0,8
27,Dual hijack model of Vif in HIV infection WP3300,0.03027168358824712,5.527165932452276,19.331497965869296,"['UBB', 'ELOB', 'ELOC', 'RBX1']",0.6110395390960993,0,0,4
28,Synaptic Vesicle Pathway WP2267,0.0351523885719845,1.9369933677229183,6.485175262732228,"['NAPA', 'SNAP25', 'RAB3A', 'UNC13A', 'STXBP1', 'CLTA', 'PARK7', 'SYP', 'AP2A2', 'AP2S1', 'SLC25A4', 'AP2M1', 'VAMP2', 'STX1A']",0.6842161347046983,0,0,14
29,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.045229985308240524,3.454829232464194,10.69613409975051,"['RPH3A', 'MADD', 'GCC2', 'SYTL2', 'EXPH5']",0.7831500527516375,0,0,5
30,RalA downstream regulated genes WP2290,0.045229985308240524,3.454829232464194,10.69613409975051,"['CDC42', 'RALBP1', 'RAC3', 'RAC1', 'HRAS']",0.7831500527516375,0,0,5
31,DNA Mismatch Repair WP531,0.0485135314440818,2.3699579831932773,7.171285535836326,"['POLE4', 'POLD4', 'RFC3', 'LIG1', 'RFC2', 'POLD2', 'POLE3', 'RPA1']",0.7831500527516375,0,0,8
32,Eukaryotic Transcription Initiation WP405,0.05108904437128412,1.8601384390677589,5.532396216586856,"['GTF2A2', 'GTF2H3', 'POLR3D', 'ERCC2', 'POLR2E', 'POLR2F', 'POLR1E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.7831500527516375,0,0,13
33,Biomarkers for urea cycle disorders WP4583,0.05135515979650546,4.145007342143906,12.306484788196016,"['GAMT', 'GATM', 'GOT1', 'ASS1']",0.7831500527516375,0,0,4
34,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.05135515979650546,4.145007342143906,12.306484788196016,"['CUL2', 'ELOB', 'ELOC', 'RBX1']",0.7831500527516375,0,0,4
35,Mitochondrial CII Assembly WP4920,0.05135515979650546,4.145007342143906,12.306484788196016,"['SDHAF1', 'SDHAF4', 'SDHC', 'SDHD']",0.7831500527516375,0,0,4
36,Glycolysis and Gluconeogenesis WP534,0.05173101265882376,2.0741353936718174,6.1429622723838815,"['PFKL', 'TPI1', 'MDH1', 'GOT1', 'MDH2', 'MPC2', 'PGK1', 'SLC2A3', 'ALDOA', 'GCK']",0.7831500527516375,0,0,10
37,Ovarian infertility WP34,0.05934354176356677,2.4188717383314957,6.831890315736188,"['EGR1', 'CEBPB', 'CDKN1B', 'CCND2', 'SMAD3', 'CDK4', 'MSH5']",0.8741143313822674,0,0,7
38,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.06334545605128308,2.0737403457153367,5.721765034858423,"['CREB3', 'CAMK4', 'CAMK2A', 'CALM3', 'CAMK1', 'CALM1', 'CALM2', 'CAMK1G', 'ATF4']",0.9085071986302443,0,0,9
39,16p11.2 proximal deletion syndrome WP4949,0.06795647550793765,1.5895736829708722,4.274185354547196,"['CCT3', 'IGBP1', 'UNC13A', 'PRRT2', 'DOC2A', 'MAZ', 'KIF22', 'SEZ6L2', 'CORO1A', 'PPP2CB', 'HIRIP3', 'ASPHD1', 'KCTD13', 'TMEM219', 'ALDOA', 'CCT7', 'CDIPT', 'CCT4']",0.9496481833801543,0,0,18
40,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.07135501558033633,1.7398205905067428,4.593278840433523,"['XBP1', 'PPP1R11', 'HSPA5', 'EIF2S1', 'PPP1CB', 'PPP1R2', 'MAP1LC3A', 'PPP1R1A', 'PPP1R7', 'DDIT3', 'PPP1R1B', 'PPP1R12C', 'ATF4']",0.9722120872820825,0,0,13
41,Androgen receptor signaling pathway WP138,0.07550893970678016,1.50298077780467,3.8829571865828014,"['SMARCE1', 'JUN', 'UBE2I', 'SMAD3', 'DSTN', 'PARK7', 'RNF4', 'RHOA', 'RHOB', 'CDC42', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'RACK1', 'CTNNB1', 'KAT7', 'RAC1', 'CALR', 'FKBP4', 'RAN']",0.9927844174392313,0,0,21
42,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.07650815694027104,2.2326067904899216,5.738598539849111,"['CEBPA', 'TTC9', 'CEBPB', 'PNCK', 'TPM3', 'TNFRSF11A', 'BCL2L1']",0.9927844174392313,0,0,7
43,7q11.23 copy number variation syndrome WP4932,0.08498922006453118,1.446630818349857,3.5662789267375374,"['SNAP25', 'RFC2', 'ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'DEK', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'CTNNB1', 'SQSTM1', 'STX1A', 'VAMP2', 'EIF2A', 'ATF4', 'ATPAF1']",0.9995549766482514,0,0,23
44,Cytosolic DNA-sensing pathway WP4655,0.08627592477464281,1.7164186684272003,4.205577073336489,"['POLR3GL', 'POLR3D', 'POLR2E', 'POLR3F', 'POLR2F', 'ADAR', 'ISG15', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.9995549766482514,0,0,12
45,DNA Repair Pathways Full Network WP4946,0.10515190589737994,1.3516451335055986,3.044376904728274,"['FEN1', 'PRKDC', 'CETN2', 'HMGB1', 'POLD4', 'NTHL1', 'POLD2', 'MBD4', 'XRCC6', 'RFC3', 'LIG1', 'PARP1', 'CENPX', 'RFC2', 'PARP2', 'RPA1', 'LIG3', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'NEIL2', 'APEX1', 'ERCC2', 'POLE3']",0.9995549766482514,0,0,28
46,DNA Replication WP466,0.1085614841913627,1.727832965415747,3.8365469968115105,"['POLD4', 'RFC3', 'ORC6', 'RFC2', 'UBC', 'POLD2', 'RPA1', 'MCM4', 'MCM6', 'UBA52']",0.9995549766482514,0,0,10
47,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.11243240461941884,1.777018861976567,3.883502504393225,"['PFKL', 'BNIP3', 'IGFBP2', 'PGK1', 'TGFA', 'BAX', 'SLC2A3', 'HIF1AN', 'BCL2L1']",0.9995549766482514,0,0,9
48,Unfolded protein response WP4925,0.1185479388900071,1.9345828739434032,4.125377749425887,"['XBP1', 'HSPA5', 'DDIT3', 'RTCB', 'EIF2S1', 'BBC3', 'ATF4']",0.9995549766482514,0,0,7
49,Methionine De Novo and Salvage Pathway WP3580,0.11976458550102491,2.072556943423953,4.398436823582654,"['ODC1', 'SMS', 'TXN', 'MAT2B', 'ENOPH1', 'SRM']",0.9995549766482514,0,0,6
50,Spinal Cord Injury WP2431,0.1277886781181055,1.4076161472340873,2.895997552896981,"['EGR1', 'CDKN1B', 'GADD45A', 'BDNF', 'NCAN', 'RHOA', 'RGMA', 'RHOB', 'CDC42', 'FKBP1A', 'GAP43', 'PTPRA', 'CDK4', 'APEX1', 'SLIT1', 'NOX4', 'RAC1', 'CD47', 'E2F5']",0.9995549766482514,0,0,19
51,CAMKK2  Pathway WP4874,0.13243958613516837,1.6960948209569027,3.4288739530951142,"['FIS1', 'MAP1LC3A', 'CAMK4', 'RAC1', 'CAMK1', 'CALM1', 'SQSTM1', 'CALM2', 'CAMKK2']",0.9995549766482514,0,0,9
52,Intraflagellar transport proteins binding to dynein WP4532,0.1380060742738261,1.7455108359133127,3.4569101630183128,"['IFT22', 'DYNC1LI2', 'DYNLT1', 'DYNLT3', 'IFT122', 'IFT27', 'DYNLL1', 'DYNLL2']",0.9995549766482514,0,0,8
53,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.13871443538753792,3.1076146788990826,6.138588993981823,"['STAT1', 'STAT2', 'BLVRA']",0.9995549766482514,0,0,3
54,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.13871443538753792,3.1076146788990826,6.138588993981823,"['JUN', 'UBE2N', 'UBE2V1']",0.9995549766482514,0,0,3
55,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.13871443538753792,3.1076146788990826,6.138588993981823,"['MEF2C', 'CCND2', 'MEF2D']",0.9995549766482514,0,0,3
56,Sulfation Biotransformation Reaction WP692,0.13871443538753792,3.1076146788990826,6.138588993981823,"['SULT1A1', 'G6PD', 'SULT4A1']",0.9995549766482514,0,0,3
57,Gastric Cancer Network 2 WP2363,0.14323331841608997,1.81351065784638,3.524159682155844,"['OTUD5', 'RFC3', 'S100A6', 'CTNNB1', 'BRIX1', 'CACYBP', 'COL9A3']",0.9995549766482514,0,0,7
58,Gastrin signaling pathway WP4659,0.1436274147708103,1.3423003347680535,2.604777733011921,"['EGR1', 'MEF2C', 'JUN', 'JAG1', 'CDKN1B', 'RPS6', 'PRKCD', 'ARRB2', 'ELAVL1', 'RHOA', 'RHOB', 'CDC42', 'MAPK9', 'PAK1', 'KAT5', 'CCKBR', 'CTNNB1', 'RAC1', 'HRAS', 'MEF2D', 'BCAR1', 'BCL2L1']",0.9995549766482514,0,0,22
59,G Protein Signaling Pathways WP35,0.14640464636657358,1.3601472261907646,2.6133609566523317,"['PRKCG', 'PDE1B', 'PDE4C', 'PRKCD', 'AKAP5', 'ADCY1', 'ADCY7', 'RHOA', 'GNAO1', 'GNG10', 'GNG3', 'GNAL', 'PRKAR1A', 'GNG7', 'GNB2', 'GNB1', 'GNB5', 'CALM1', 'HRAS', 'CALM2']",0.9995549766482514,0,0,20
60,Canonical and non-canonical Notch signaling WP3845,0.14765122983557588,1.9129599276550049,3.6593055246714106,"['JAG1', 'MFAP1', 'NOTCH4', 'PSEN2', 'DLL3', 'DLK2']",0.9995549766482514,0,0,6
61,Striated Muscle Contraction Pathway WP383,0.14765122983557588,1.9129599276550049,3.6593055246714106,"['TPM4', 'ACTN2', 'TPM3', 'TPM1', 'ACTN4', 'ACTG1']",0.9995549766482514,0,0,6
62,Cell cycle WP179,0.14822603557563563,1.325369685767098,2.5301531327230684,"['YWHAE', 'CDKN2D', 'ANAPC13', 'SMAD3', 'CDKN1B', 'GADD45B', 'PRKDC', 'GADD45A', 'YWHAB', 'YWHAZ', 'RBX1', 'ANAPC11', 'CCND2', 'CDC23', 'ORC6', 'YWHAQ', 'CDK4', 'MCM4', 'E2F3', 'MCM6', 'E2F5', 'SKP1', 'YWHAH']",0.9995549766482514,0,0,23
63,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.14917036251528412,2.367946297461716,4.505411510525754,"['JAG1', 'H2AFY', 'CDK4', 'CTNNB1']",0.9995549766482514,0,0,4
64,NO metabolism in cystic fibrosis WP4947,0.14917036251528412,2.367946297461716,4.505411510525754,"['PRMT6', 'PRMT5', 'PRMT8', 'PRMT2']",0.9995549766482514,0,0,4
65,Exercise-induced Circadian Regulation WP410,0.15022113993997993,1.5078323738117552,2.8583176208106336,"['DNAJA1', 'DAZAP2', 'PPP2CB', 'HSPA8', 'CEBPB', 'SUMO1', 'CBX3', 'STBD1', 'KLF9', 'CRY2', 'AZIN1', 'EIF4G2']",0.9995549766482514,0,0,12
66,Selenium Micronutrient Network WP15,0.15988758439467696,1.45691105470111,2.670932175054189,"['GPX4', 'SELENOF', 'TXN', 'SELENOK', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'PRDX1', 'CAT', 'SELENOW', 'SEPHS2', 'MSRB1']",0.9995549766482514,0,0,13
67,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.1689591693508359,1.280470259382579,2.2768018566056094,"['YWHAE', 'SNAP25', 'CEBPB', 'YWHAB', 'MAZ', 'HSP90B1', 'NEUROD1', 'YWHAQ', 'SCN3B', 'YWHAH', 'EGR1', 'MEF2C', 'JUN', 'TSPYL1', 'BDNF', 'MBD1', 'SSTR1', 'YWHAZ', 'GCK', 'ADCYAP1', 'PRKAR1A', 'CTNNB1', 'ALDOA', 'SLC25A4', 'VAMP2']",0.9995549766482514,0,0,25
68,Aryl Hydrocarbon Receptor Pathway WP2873,0.1701400772113028,1.7066822318784185,3.0227615586750485,"['SLC7A5', 'JUN', 'CDKN1B', 'PTGES3', 'CDC37', 'BAX', 'CAP2']",0.9995549766482514,0,0,7
69,Cell migration and invasion through p75NTR WP4561,0.1701400772113028,1.7066822318784185,3.0227615586750485,"['ARF1', 'PAK1', 'JUN', 'EFNB3', 'BDNF', 'RAC1', 'RHOA']",0.9995549766482514,0,0,7
70,Pre-implantation embryo WP3527,0.1701400772113028,1.7066822318784185,3.0227615586750485,"['EGR1', 'BATF3', 'DDIT3', 'HMGA1', 'E2F5', 'MXD1', 'ELAVL1']",0.9995549766482514,0,0,7
71,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.17244493833578428,4.142699926632428,7.281529586617959,"['GGCT', 'GSS']",0.9995549766482514,0,0,2
72,"Phase I biotransformations, non P450 WP136",0.17244493833578428,4.142699926632428,7.281529586617959,"['ESD', 'CES2']",0.9995549766482514,0,0,2
73,Role of Osx and miRNAs in tooth development WP3971,0.17244493833578428,4.142699926632428,7.281529586617959,"['NOTCH4', 'CTNNB1']",0.9995549766482514,0,0,2
74,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.17244493833578428,4.142699926632428,7.281529586617959,"['RIPPLY2', 'DLL3']",0.9995549766482514,0,0,2
75,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.18527606377936123,1.2323760174386602,2.0776729929218845,"['RAB3A', 'CRTC1', 'CAMK2A', 'PTPRF', 'CDC42', 'MAPK9', 'DPYSL2', 'CFL1', 'RACK1', 'RAC1', 'IKBKG', 'HRAS', 'SH2B1', 'EGR1', 'MEF2C', 'JUN', 'CSNK2A1', 'BDNF', 'STAT1', 'RPS6', 'PRKCD', 'EIF2S2', 'EIF2S1', 'MARCKS', 'DOK5', 'CAMK4', 'CTNNB1', 'MAPT', 'CAMK1', 'SQSTM1']",0.9995549766482514,0,0,30
76,Retinoblastoma gene in cancer WP2446,0.18932165874116536,1.3301086419409394,2.2137102041344994,"['PLK4', 'RFC3', 'CDKN1B', 'RRM2', 'PRMT2', 'H2AFZ', 'PRKDC', 'SUV39H1', 'HMGB2', 'RPA1', 'HMGB1', 'RBBP4', 'CDK4', 'STMN1', 'MCM4', 'E2F3', 'MCM6']",0.9995549766482514,0,0,17
77,Airway smooth muscle cell contraction WP4962,0.19103731957910275,2.071769456681351,3.429371970400129,"['PPP1CB', 'CALM1', 'CALM2', 'RHOA']",0.9995549766482514,0,0,4
78,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.19103731957910275,2.071769456681351,3.429371970400129,"['CD63', 'CD81', 'SORBS2', 'SOD1']",0.9995549766482514,0,0,4
79,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.19113001499026483,2.4858715596330274,4.113623676833331,"['UBE2N', 'UBE2V1', 'SQSTM1']",0.9995549766482514,0,0,3
80,Hfe effect on hepcidin production WP3924,0.1945372968346877,inf,inf,['SMAD7'],0.9995549766482514,0,0,1
81,Pancreatic adenocarcinoma pathway WP4263,0.20015859649679976,1.291662884495519,2.07782735624639,"['RALBP1', 'SMAD3', 'GADD45B', 'STAT1', 'GADD45A', 'PRKCD', 'PEBP1', 'TGFA', 'RHOA', 'CDC42', 'MAPK9', 'PAK1', 'CDK4', 'RAC3', 'BAX', 'E2F3', 'RAC1', 'IKBKG', 'BCL2L1']",0.9995549766482514,0,0,19
82,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2127525240061607,1.323179960944546,2.0477872443190233,"['PSMD10', 'HSPA8', 'HSPA5', 'PSMD13', 'SIAH2', 'UBE2G2', 'UBE2J2', 'SNCAIP', 'PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC1', 'SNCA']",0.9995549766482514,0,0,15
83,The influence of laminopathies on Wnt signaling WP4844,0.22967978785144044,1.5267606723534304,2.245970550242891,"['CEBPA', 'WNT10B', 'CEBPB', 'AGO2', 'CTNNB1', 'EMD', 'TOR1AIP1']",0.9995549766482514,0,0,7
84,Cori Cycle WP1946,0.23600697997116674,1.841409691629956,2.6588002179134813,"['G6PD', 'TPI1', 'PGK1', 'ALDOA']",0.9995549766482514,0,0,4
85,Fatty acid transporters WP5061,0.23600697997116674,1.841409691629956,2.6588002179134813,"['FABP3', 'FABP5', 'FABP7', 'ACSL3']",0.9995549766482514,0,0,4
86,TP53 network WP1742,0.23600697997116674,1.841409691629956,2.6588002179134813,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.9995549766482514,0,0,4
87,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.24552084991866066,1.5538666421748715,2.1822089902453454,"['RBBP4', 'H3F3B', 'CBX3', 'SUV39H1', 'H3F3A', 'CBX1']",0.9995549766482514,0,0,6
88,Genes targeted by miRNAs in adipocytes WP1992,0.24742893431767526,2.0713761467889906,2.8929499460741726,"['HCN4', 'TMSB4X', 'KCNJ2']",0.9995549766482514,0,0,3
89,Glutathione metabolism WP100,0.24742893431767526,2.0713761467889906,2.8929499460741726,"['G6PD', 'GPX4', 'GSS']",0.9995549766482514,0,0,3
90,miR-509-3p alteration of YAP1/ECM axis WP3967,0.24742893431767526,2.0713761467889906,2.8929499460741726,"['SPARC', 'GPC6', 'BCAR1']",0.9995549766482514,0,0,3
91,Metastatic brain tumor WP2249,0.25155603131922555,2.7615553925165077,3.8111936718810973,"['CDC42', 'E2F3']",0.9995549766482514,0,0,2
92,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.2559115744475587,1.308852026974653,1.7838649323043763,"['ACTR2', 'PAK1', 'JUN', 'CDKN1B', 'TMSB4X', 'TGFA', 'CTNNB1', 'CAMK1', 'PFN1', 'RHOA', 'PFN2', 'SOD1']",0.9995549766482514,0,0,12
93,Globo Sphingolipid Metabolism WP1424,0.2631919687310839,1.5935478403344727,2.1271817456408435,"['B3GALNT1', 'ST6GAL1', 'ST6GAL2', 'FUT9', 'FUT1']",0.9995549766482514,0,0,5
94,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.2631919687310839,1.5935478403344727,2.1271817456408435,"['MDH2', 'IDH2', 'IDH3B', 'SDHC', 'SDHD']",0.9995549766482514,0,0,5
95,G13 Signaling Pathway WP524,0.2742124215220964,1.38125,1.7871333677201933,"['CDC42', 'PPP1CB', 'CFL1', 'RAC1', 'PFN1', 'CALM1', 'CALM2', 'RHOA']",0.9995549766482514,0,0,8
96,AGE/RAGE pathway WP2324,0.27971444954857666,1.275178429817605,1.6245594916074988,"['CDC42', 'MAPK9', 'JUN', 'SMAD3', 'STAT1', 'PRKCD', 'PLA2G4A', 'CYCS', 'RAC1', 'DDOST', 'RHOA', 'SOD1']",0.9995549766482514,0,0,12
97,NAD+ metabolism WP3644,0.28310090907576274,1.65712187958884,2.091208064247555,"['NT5E', 'PARP1', 'NMNAT2', 'NADK']",0.9995549766482514,0,0,4
98,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.28310090907576274,1.65712187958884,2.091208064247555,"['GSK3A', 'BAX', 'BCL2L2', 'BCL2L1']",0.9995549766482514,0,0,4
99,Common Pathways Underlying Drug Addiction WP2636,0.2840608806731065,1.3319366363684129,1.6763310906863766,"['PPP1CB', 'PRKCG', 'PPP1R1A', 'CAMK4', 'CAMK2A', 'ADCY1', 'CALM1', 'CALM2', 'ACTG1']",0.9995549766482514,0,0,9
100,Amyotrophic lateral sclerosis (ALS) WP2447,0.3051591279915082,1.3258823529411765,1.5737188112207985,"['CCS', 'TOMM40', 'CAT', 'BAX', 'RAC1', 'RAB5A', 'SOD1', 'BCL2L1']",0.9995549766482514,0,0,8
101,p38 MAPK Signaling Pathway WP400,0.3051591279915082,1.3258823529411765,1.5737188112207985,"['CDC42', 'STAT1', 'DDIT3', 'PLA2G4A', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9995549766482514,0,0,8
102,Parkinson's disease pathway WP2371,0.3051591279915082,1.3258823529411765,1.5737188112207985,"['UBB', 'SYT11', 'CYCS', 'PARK7', 'UBE2G2', 'UBE2J2', 'SNCAIP', 'SNCA']",0.9995549766482514,0,0,8
103,Osteoclast Signaling WP12,0.30573824923745213,1.775307994757536,2.103786021260204,"['ATP6V1G1', 'TNFRSF11A', 'IFNAR1']",0.9995549766482514,0,0,3
104,Transcriptional cascade regulating adipogenesis WP4211,0.30573824923745213,1.775307994757536,2.103786021260204,"['CEBPA', 'CEBPB', 'DDIT3']",0.9995549766482514,0,0,3
105,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.31286939231630206,1.208686440677966,1.4044567216836452,"['EGR1', 'JUN', 'CDKN1B', 'STAT1', 'RPS6', 'TTF2', 'TTF1', 'MYL12B', 'GNAO1', 'GNG2', 'CDK4', 'APEX1', 'GNB1', 'HRAS']",0.9995549766482514,0,0,14
106,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3247857762182175,1.231863442389758,1.3853406485031579,"['PRKCG', 'RXRB', 'IFI27L2', 'MAPK9', 'JUN', 'STAT1', 'STAT2', 'PRKCD', 'CAMK2A', 'ISG15', 'HRAS']",0.9995549766482514,0,0,11
107,Peroxiredoxin 2 induced ovarian failure WP4873,0.3312145567472082,2.070983125458547,2.288413377949083,"['PARP2', 'BAX']",0.9995549766482514,0,0,2
108,Serotonin Transporter Activity WP1455,0.3312145567472082,2.070983125458547,2.288413377949083,"['PPP2CB', 'STX1A']",0.9995549766482514,0,0,2
109,Proximal tubule transport WP4917,0.3368009333658013,1.2747737556561085,1.3872893989112347,"['ABCC4', 'ATP6V1G1', 'SLC22A6', 'ATP6V1E1', 'SLC22A8', 'SLC4A4', 'ATP6V1D', 'ATP6V1F']",0.9995549766482514,0,0,8
110,B Cell Receptor Signaling Pathway WP23,0.34084976905796255,1.1631734202763546,1.2519392070699673,"['PTPN18', 'MEF2C', 'JUN', 'GSK3A', 'CD81', 'PRKCD', 'CAMK2A', 'ILF2', 'CDC42', 'MAPK9', 'INPP5D', 'E2F3', 'RAC1', 'IKBKG', 'HRAS', 'MEF2D']",0.9995549766482514,0,0,16
111,Regulation of Microtubule Cytoskeleton WP2038,0.34279474438887403,1.242920191246782,1.330699470659127,"['CDC42', 'PAK1', 'PTPRA', 'DPYSL2', 'CAMK4', 'STMN1', 'TESK2', 'RAC1', 'MAPT']",0.9995549766482514,0,0,9
112,Aflatoxin B1 metabolism WP699,0.351241014477238,4.141547488082142,4.333229240430654,['AKR7A2'],0.9995549766482514,0,0,1
113,Arylamine metabolism WP694,0.351241014477238,4.141547488082142,4.333229240430654,['SULT1A1'],0.9995549766482514,0,0,1
114,Gastric acid production WP2596,0.351241014477238,4.141547488082142,4.333229240430654,['CCK'],0.9995549766482514,0,0,1
115,MED and Pseudoachondroplasia genes WP4789,0.351241014477238,4.141547488082142,4.333229240430654,['COL9A3'],0.9995549766482514,0,0,1
116,Nanomaterial-induced inflammasome activation WP3890,0.351241014477238,4.141547488082142,4.333229240430654,['CTSB'],0.9995549766482514,0,0,1
117,G1 to S cell cycle control WP45,0.351394180257814,1.1993394417217131,1.2543251552733432,"['CDKN2D', 'CREB3', 'CDKN1B', 'CCND2', 'ORC6', 'GADD45A', 'CDK4', 'RPA1', 'MCM4', 'E2F3', 'MCM6']",0.9995549766482514,0,0,11
118,Neural Crest Cell Migration during Development WP4564,0.3636797717167172,1.2607896713164917,1.2752654866575694,"['ARF1', 'PAK1', 'JUN', 'BDNF', 'RAC1', 'RHOA', 'NGEF']",0.9995549766482514,0,0,7
119,Computational Model of Aerobic Glycolysis WP4629,0.36445119292998707,1.5532568807339449,1.5677994625138092,"['TPI1', 'PGK1', 'ALDOA']",0.9995549766482514,0,0,3
120,GDNF/RET signaling axis WP4830,0.36445119292998707,1.5532568807339449,1.5677994625138092,"['ROBO2', 'IFT27', 'CTNNB1']",0.9995549766482514,0,0,3
121,Homologous recombination WP186,0.36445119292998707,1.5532568807339449,1.5677994625138092,"['POLD4', 'POLD2', 'RPA1']",0.9995549766482514,0,0,3
122,Fas ligand pathway and stress induction of heat shock proteins WP314,0.368898723572979,1.227450980392157,1.224054788590889,"['PAK1', 'JUN', 'PARP1', 'PRKDC', 'RIPK2', 'CYCS', 'ACTG1', 'LMNB1']",0.9995549766482514,0,0,8
123,Histone Modifications WP2369,0.37285716669643937,1.2027192160305615,1.186554505937393,"['SET', 'H3F3B', 'SMYD5', 'SUV39H1', 'EHMT2', 'H3F3A', 'PRDM2', 'KMT5A', 'HIST1H4C']",0.9995549766482514,0,0,9
124,DNA damage response (only ATM dependent) WP710,0.3856944756457482,1.1130913697196674,1.060452985881,"['WNT10B', 'WNT10A', 'JUN', 'SMAD3', 'CDKN1B', 'PIK3C2G', 'HMGB1', 'RHOA', 'BBC3', 'CDC42', 'MAPK9', 'CCND2', 'CAT', 'RAC3', 'CTNNB1', 'BAX', 'RAC1', 'HRAS']",0.9995549766482514,0,0,18
125,Genes related to primary cilium development (based on CRISPR) WP4536,0.3863880438765887,1.1013920777356407,1.0473281764001026,"['MKKS', 'DYNLT1', 'ARL6', 'ARL3', 'IFT122', 'TUBD1', 'DYNLL1', 'TXNDC15', 'LZTFL1', 'IFT20', 'TMEM17', 'KIF3B', 'TCTN3', 'BBS12', 'TMEM216', 'TMEM107', 'IFT27', 'FOPNL', 'B9D1', 'CLUAP1', 'BBS4']",0.9995549766482514,0,0,21
126,Chemokine signaling pathway WP3929,0.3864535818318878,1.0982466451170536,1.0441508778245017,"['STAT1', 'STAT2', 'PRKCD', 'ARRB2', 'ADCY1', 'ADCY7', 'CDC42', 'GNG10', 'GNG3', 'PAK1', 'GNG2', 'GNB2', 'GNG7', 'GRK6', 'GNB1', 'GNB5', 'RAC1', 'IKBKG', 'HRAS', 'JAK3', 'CCL28', 'BCAR1']",0.9995549766482514,0,0,22
127,Zinc homeostasis WP3529,0.39467066751565516,1.2426524614254224,1.1552984855403101,"['SLC30A3', 'SLC30A4', 'SLC39A10', 'SLC30A1', 'SLC30A10', 'SLC39A3']",0.9995549766482514,0,0,6
128,IL-18 signaling pathway WP4754,0.3970082325439329,1.0647296544035674,0.9835954038369756,"['MTCH1', 'CEBPB', 'NRN1', 'TOMM40', 'ANP32A', 'CD81', 'HSPB8', 'COX17', 'PRCC', 'FUT1', 'ELAVL1', 'CENPB', 'RXRB', 'MAPK9', 'TMSB4X', 'STMN1', 'RAE1', 'ABCF1', 'CA11', 'JUN', 'PARP1', 'IMP3', 'PRKCD', 'NDUFC1', 'BPGM', 'DEK', 'ARFGAP2', 'ARL4D', 'CCDC9', 'NACA', 'CTNNB1', 'CYCS', 'BAX', 'CDK5R2', 'AARS', 'ITM2C', 'BCL2L1']",0.9995549766482514,0,0,37
129,IL-2 signaling pathway WP49,0.39852782118665997,1.2081495773612643,1.1114709937243832,"['JUN', 'CCND2', 'STAT1', 'RPS6', 'MAPT', 'HRAS', 'JAK3']",0.9995549766482514,0,0,7
130,Cell Differentiation - Index WP2029,0.40821457953525375,1.656639765223771,1.4842867951906098,"['MEF2C', 'MEF2D']",0.9995549766482514,0,0,2
131,"Cerebral organic acidurias, including diseases WP4519",0.40821457953525375,1.656639765223771,1.4842867951906098,"['MDH2', 'IDH2']",0.9995549766482514,0,0,2
132,Supression of HMGB1 mediated inflammation by THBD WP4479,0.40821457953525375,1.656639765223771,1.4842867951906098,"['HMGB1', 'IKBKG']",0.9995549766482514,0,0,2
133,Type III interferon signaling WP2113,0.40821457953525375,1.656639765223771,1.4842867951906098,"['STAT1', 'STAT2']",0.9995549766482514,0,0,2
134,Cell Differentiation - Index expanded WP2023,0.42225579719764006,1.3805504587155963,1.1902332865154006,"['MEF2C', 'PAX7', 'MEF2D']",0.9995549766482514,0,0,3
135,Galanin receptor pathway WP4970,0.42225579719764006,1.3805504587155963,1.1902332865154006,"['CDKN1B', 'PRKCD', 'VAMP2']",0.9995549766482514,0,0,3
136,NOTCH1 regulation of endothelial cell calcification WP3413,0.42225579719764006,1.3805504587155963,1.1902332865154006,"['JAG1', 'CALU', 'DLL3']",0.9995549766482514,0,0,3
137,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4282014471720275,1.2743702699649837,1.0808718292541442,"['RAB5C', 'MRAS', 'HRAS', 'RAB5A']",0.9995549766482514,0,0,4
138,Senescence and Autophagy in Cancer WP615,0.4290880890122479,1.0865128874703807,0.919290997869321,"['GABARAPL2', 'ATG3', 'GABARAPL1', 'JUN', 'CEBPB', 'SPARC', 'SMAD3', 'CDKN1B', 'HMGA1', 'GABARAP', 'ING2', 'MAP1LC3A', 'CREG1', 'SQSTM1', 'HRAS', 'SLC39A3']",0.9995549766482514,0,0,16
139,Physiological and pathological hypertrophy of the heart WP1528,0.4311459306648774,1.2181633578881423,1.0248513822328098,"['JUN', 'RAC1', 'CALM1', 'CALM2', 'RHOA']",0.9995549766482514,0,0,5
140,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.43264353487018004,1.1833735698540988,0.9914790550559102,"['NDUFA13', 'COPS6', 'RIPK2', 'RAC1', 'NLRP1', 'IKBKG']",0.9995549766482514,0,0,6
141,Disruption of postsynaptic signaling by CNV WP4875,0.4333361214611277,1.1597206909224549,0.969806674625964,"['NLGN3', 'RPH3A', 'SYNGAP1', 'FMR1', 'CAMK2A', 'NRXN2', 'STX1A']",0.9995549766482514,0,0,7
142,ATM Signaling Network in Development and Disease  WP3878,0.43342383224031766,1.1296265338192517,0.9444120663146538,"['MDC1', 'G6PD', 'RIF1', 'KAT5', 'PRKDC', 'RNF8', 'TP53BP1', 'IKBKG', 'HMGN1']",0.9995549766482514,0,0,9
143,Copper homeostasis WP3286,0.46356975938507905,1.0963048698699782,0.8428374294471519,"['BACE1', 'JUN', 'CCS', 'SCO1', 'COX17', 'COX11', 'MAPT', 'ATOX1', 'SOD1']",0.9995549766482514,0,0,9
144,PDGF Pathway WP2526,0.465647188671611,1.1044117647058824,0.8441317722544827,"['CDC42', 'PAK1', 'JUN', 'STAT1', 'PLA2G4A', 'RAC1', 'HRAS', 'RHOA']",0.9995549766482514,0,0,8
145,TGF-beta Receptor Signaling WP560,0.465647188671611,1.1044117647058824,0.8441317722544827,"['FKBP1A', 'MAPK9', 'JUN', 'SMAD3', 'STAT1', 'CTNNB1', 'HRAS', 'SMAD7']",0.9995549766482514,0,0,8
146,Neural Crest Cell Migration in Cancer WP4565,0.46784529856391366,1.1150171034404772,0.8469866119880382,"['ARF1', 'PAK1', 'JUN', 'BDNF', 'RAC1', 'RHOA', 'NGEF']",0.9995549766482514,0,0,7
147,Type 2 papillary renal cell carcinoma WP4241,0.46784529856391366,1.1150171034404772,0.8469866119880382,"['CUL2', 'PRCC', 'TGFA', 'ELOB', 'ELOC', 'VHL', 'RBX1']",0.9995549766482514,0,0,7
148,Tumor suppressor activity of SMARCB1 WP4204,0.4701830421670302,1.1294836684256229,0.8523458848504211,"['SMARCE1', 'SMARCD1', 'RBBP4', 'H3F3B', 'CDK4', 'H3F3A']",0.9995549766482514,0,0,6
149,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4726802470988135,1.1503856041131106,0.8620254959612956,"['YWHAQ', 'LPL', 'RAC1', 'NDRG1', 'RHOA']",0.9995549766482514,0,0,5
150,Wnt signaling in kidney disease WP4150,0.4726802470988135,1.1503856041131106,0.8620254959612956,"['MAPK9', 'WNT10B', 'WNT10A', 'CTNNB1', 'RHOA']",0.9995549766482514,0,0,5
151,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.47534699186834045,1.1832389343402558,0.8799869028937519,"['H3F3B', 'H2AFY', 'H2AFZ', 'H3F3A']",0.9995549766482514,0,0,4
152,GABA metabolism (aka GHB) WP4157,0.4774668112537259,2.0705903923725706,1.530705951114184,['AKR7A2'],0.9995549766482514,0,0,1
153,Gene regulatory network modelling somitogenesis  WP2854,0.4774668112537259,2.0705903923725706,1.530705951114184,['RIPPLY2'],0.9995549766482514,0,0,1
154,Hypothetical Craniofacial Development Pathway WP3655,0.4774668112537259,2.0705903923725706,1.530705951114184,['RHOA'],0.9995549766482514,0,0,1
155,let-7 inhibition of ES cell reprogramming WP3299,0.4774668112537259,2.0705903923725706,1.530705951114184,['EGR1'],0.9995549766482514,0,0,1
156,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.4774668112537259,2.0705903923725706,1.530705951114184,['MAS1'],0.9995549766482514,0,0,1
157,Biomarkers for pyrimidine metabolism disorders WP4584,0.4781304168954886,1.2423853211009175,0.9167210248566587,"['RRM2', 'PUS1', 'TK2']",0.9995549766482514,0,0,3
158,BMP Signaling Pathway in Eyelid Development WP3927,0.4781304168954886,1.2423853211009175,0.9167210248566587,"['MAPK9', 'JUN', 'TGFA']",0.9995549766482514,0,0,3
159,Nicotine Activity on Dopaminergic Neurons WP1602,0.4781304168954886,1.2423853211009175,0.9167210248566587,"['GNG2', 'GNB1', 'PPP1R1B']",0.9995549766482514,0,0,3
160,Omega-3/Omega-6 FA synthesis WP4723,0.4781304168954886,1.2423853211009175,0.9167210248566587,"['ACOX1', 'PLA2G4A', 'ACSL3']",0.9995549766482514,0,0,3
161,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.48057606637170797,1.380410858400587,1.0115233284366834,"['JAG1', 'VHL']",0.9995549766482514,0,0,2
162,ATR Signaling WP3875,0.48057606637170797,1.380410858400587,1.0115233284366834,"['RPA1', 'RAD1']",0.9995549766482514,0,0,2
163,"Degradation pathway of sphingolipids, including diseases WP4153",0.48057606637170797,1.380410858400587,1.0115233284366834,"['NEU3', 'GM2A']",0.9995549766482514,0,0,2
164,Metabolic reprogramming in colon cancer WP4290,0.49735103172415485,1.0686907020872864,0.7464368538351093,"['G6PD', 'PFKL', 'MDH2', 'PPAT', 'IDH2', 'PGK1', 'PYCR2', 'PDHB']",0.9995549766482514,0,0,8
165,Joubert Syndrome WP4656,0.5018875170706447,1.035280029476787,0.71370057437917,"['PARP1', 'CETN2', 'ARL3', 'ARL2', 'RHOA', 'TMEM17', 'KAT5', 'TCTN3', 'TMEM216', 'B9D1', 'CEP41', 'RAB8A', 'BBS4', 'ATF4']",0.9995549766482514,0,0,14
166,Ras signaling WP4223,0.5020374699302075,1.0171150097465886,0.7008741406100427,"['RAB5C', 'RASGRF2', 'CDC42', 'MAPK9', 'GNG10', 'GNG3', 'PAK1', 'SYNGAP1', 'GNG2', 'GNG7', 'RAC3', 'RAC1', 'IKBKG', 'HRAS', 'PRKCG', 'RALBP1', 'PLA2G4C', 'PLA2G4A', 'RHOA', 'MRAS', 'GNB2', 'GNB1', 'CALM3', 'GNB5', 'CALM1', 'CALM2', 'RAB5A', 'BCL2L1']",0.9995549766482514,0,0,28
167,Vitamin A and carotenoid metabolism WP716,0.5069946982381506,1.0802798453822318,0.7337851974754295,"['RXRB', 'SULT1A1', 'SDR16C5', 'CYP26B1', 'RBP4', 'LPL']",0.9995549766482514,0,0,6
168,IL-7 signaling pathway WP205,0.5209177623751748,1.1042584434654918,0.7201566046305367,"['CDKN1B', 'STAT1', 'JAK3', 'BCL2L1']",0.9995549766482514,0,0,4
169,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.522773386931628,1.0352151526296431,0.6714480050667313,"['NET1', 'BEX3', 'CDKN1B', 'HSPA5', 'RIPK2', 'SERBP1', 'RNF7', 'SQSTM1', 'SMAD7']",0.9995549766482514,0,0,9
170,Interferon type I signaling pathways WP585,0.522773386931628,1.0352151526296431,0.6714480050667313,"['EIF4A1', 'STAT1', 'STAT2', 'RPS6', 'RACK1', 'STAT4', 'RAC1', 'EIF4B', 'IFNAR1']",0.9995549766482514,0,0,9
171,RANKL/RANK signaling pathway WP2018,0.522773386931628,1.0352151526296431,0.6714480050667313,"['CDC42', 'MAPK9', 'JUN', 'STAT1', 'TRAF5', 'RAC1', 'IKBKG', 'TNFRSF11A', 'SQSTM1']",0.9995549766482514,0,0,9
172,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5284744830706924,1.035202205882353,0.6602113420923821,"['MAPK9', 'PAK1', 'JUN', 'CDK4', 'CHP1', 'IKBKG', 'CALM1', 'CALM2']",0.9995549766482514,0,0,8
173,Adipogenesis WP236,0.5312356632086109,1.0071706392739603,0.6370853306264403,"['WNT10B', 'CEBPA', 'MEF2C', 'CEBPB', 'SMAD3', 'GADD45B', 'GADD45A', 'STAT1', 'STAT2', 'CISD1', 'HMGA1', 'LPL', 'CYP26B1', 'KLF6', 'DDIT3', 'NDN', 'CTNNB1', 'MEF2D']",0.9995549766482514,0,0,18
174,Imatinib and Chronic Myeloid Leukemia WP3640,0.5313202528998346,1.1293411175979984,0.7141843983518463,"['CDKN1B', 'GADD45A', 'PIM2']",0.9995549766482514,0,0,3
175,SARS coronavirus and innate immunity WP4912,0.5313202528998346,1.1293411175979984,0.7141843983518463,"['STAT1', 'STAT2', 'IFNAR1']",0.9995549766482514,0,0,3
176,Fatty acid beta-oxidation WP143,0.5428234108318605,1.03517634092579,0.6324629542026999,"['ECHS1', 'TPI1', 'GPD2', 'LPL', 'ACSL3', 'DECR1']",0.9995549766482514,0,0,6
177,Estrogen Receptor Pathway WP2881,0.5471894915210714,1.183104496384027,0.7133648255035547,"['JUN', 'ACOX1']",0.9995549766482514,0,0,2
178,Thiamine metabolic pathways WP4297,0.5471894915210714,1.183104496384027,0.7133648255035547,"['BCKDK', 'SLC25A19']",0.9995549766482514,0,0,2
179,Trans-sulfuration pathway WP2333,0.5471894915210714,1.183104496384027,0.7133648255035547,"['GOT1', 'MAT2B']",0.9995549766482514,0,0,2
180,Fluoropyrimidine Activity WP1601,0.5523253676786853,1.0351634226955564,0.6144916118271124,"['ABCC4', 'RRM2', 'PPAT', 'ERCC2', 'CES2']",0.9995549766482514,0,0,5
181,Glycosylation and related congenital defects WP4521,0.5523253676786853,1.0351634226955564,0.6144916118271124,"['DPM2', 'DPM3', 'MPI', 'SRD5A3', 'ALG13']",0.9995549766482514,0,0,5
182,PPAR signaling pathway WP3942,0.5588614609354772,1.0037433155080213,0.5840317321572013,"['RXRB', 'FABP3', 'FABP5', 'ACOX1', 'FABP7', 'LPL', 'ACSL3', 'SLC27A5']",0.9995549766482514,0,0,8
183,SARS-CoV-2 mitochondrial interactions WP5038,0.5645067676788142,1.0351505139500734,0.5919020727094543,"['TOMM70', 'NDUFB9', 'ACAD9', 'PHB']",0.9995549766482514,0,0,4
184,Urea cycle and associated pathways WP4595,0.5645067676788142,1.0351505139500734,0.5919020727094543,"['MDH1', 'GOT1', 'MDH2', 'ASS1']",0.9995549766482514,0,0,4
185,3q29 copy number variation syndrome WP4906,0.5719125802022479,0.9857563334384526,0.5508102099083378,"['JUN', 'DYNLT1', 'NCBP2', 'DYNLT3', 'RNF8', 'UBE2N', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX']",0.9995549766482514,0,0,10
186,Metapathway biotransformation Phase I and II WP702,0.5762573532863559,0.9774529693839912,0.5387729800561859,"['GSTO2', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSS', 'AKR1A1', 'CYP46A1', 'HS3ST4', 'NAA80', 'SULT1A1', 'NDST1', 'AKR7A2', 'CYP26B1', 'CYP4X1', 'GSTA4', 'SULT4A1']",0.9995549766482514,0,0,17
187,Composition of Lipid Particles WP3601,0.5791406908883002,1.3802713604693804,0.7539178010039979,['LPL'],0.9995549766482514,0,0,1
188,Irinotecan pathway WP229,0.5791406908883002,1.3802713604693804,0.7539178010039979,['CES2'],0.9995549766482514,0,0,1
189,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.5791406908883002,1.3802713604693804,0.7539178010039979,['RAC1'],0.9995549766482514,0,0,1
190,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5791406908883002,1.3802713604693804,0.7539178010039979,['CCKBR'],0.9995549766482514,0,0,1
191,Synthesis and Degradation of Ketone Bodies WP311,0.5791406908883002,1.3802713604693804,0.7539178010039979,['OXCT1'],0.9995549766482514,0,0,1
192,Overview of interferons-mediated signaling pathway WP4558,0.5813042918220751,1.035137614678899,0.5615424067355613,"['STAT1', 'STAT2', 'IFNAR1']",0.9995549766482514,0,0,3
193,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5883761797644247,0.9741349480968858,0.5166702409675876,"['FKBP1A', 'MAPK9', 'JUN', 'SMAD3', 'STAT1', 'CTNNB1', 'HRAS', 'SMAD7']",0.9995549766482514,0,0,8
194,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5883761797644247,0.9741349480968858,0.5166702409675876,"['CEBPA', 'WNT10B', 'CEBPB', 'SMAD3', 'CDK4', 'AGO2', 'CTNNB1', 'EMD']",0.9995549766482514,0,0,8
195,Oxidation by Cytochrome P450 WP43,0.5898621769319762,0.9857824878023189,0.5203614212682963,"['CYB5A', 'CYP26B1', 'CYP4X1', 'CYB5R3', 'CYP46A1']",0.9995549766482514,0,0,5
196,Fatty Acid Biosynthesis WP357,0.6058122315215313,0.9741729290835277,0.4882410444584642,"['MECR', 'ECHS1', 'ACSL3', 'DECR1']",0.9995549766482514,0,0,4
197,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6058122315215313,0.9741729290835277,0.4882410444584642,"['CRTAP', 'TNFRSF11A', 'P4HB', 'PPIB']",0.9995549766482514,0,0,4
198,Type II interferon signaling (IFNG) WP619,0.6058122315215313,0.9741729290835277,0.4882410444584642,"['STAT1', 'STAT2', 'PRKCD', 'ISG15']",0.9995549766482514,0,0,4
199,White fat cell differentiation WP4149,0.6058122315215313,0.9741729290835277,0.4882410444584642,"['CEBPA', 'WNT10B', 'CEBPB', 'DDIT3']",0.9995549766482514,0,0,4
200,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6067053937856131,0.9552792568256486,0.4773644637636187,"['MAPK9', 'JUN', 'SMAD3', 'GADD45B', 'GADD45A', 'RAC3', 'CTNNB1', 'CYCS', 'BAX', 'RAC1', 'RHOA', 'BBC3']",0.9995549766482514,0,0,12
201,Notch Signaling Pathway Netpath WP61,0.606831551181647,0.9553285993153592,0.4771904918714307,"['PSENEN', 'NUMBL', 'JAG1', 'NOTCH4', 'PSEN2', 'CIR1', 'MAPT', 'SKP1', 'DLL3']",0.9995549766482514,0,0,9
202,Alanine and aspartate metabolism WP106,0.6075522563202306,1.0351247248716067,0.5158203394767683,"['GOT1', 'ASS1']",0.9995549766482514,0,0,2
203,Dopamine metabolism WP2436,0.6075522563202306,1.0351247248716067,0.5158203394767683,"['PPP2CB', 'SOD1']",0.9995549766482514,0,0,2
204,Nanoparticle triggered regulated necrosis WP2513,0.6075522563202306,1.0351247248716067,0.5158203394767683,"['PARP1', 'PLA2G4A']",0.9995549766482514,0,0,2
205,Non-homologous end joining WP438,0.6075522563202306,1.0351247248716067,0.5158203394767683,"['XRCC6', 'PRKDC']",0.9995549766482514,0,0,2
206,TCA cycle in senescence WP5050,0.6075522563202306,1.0351247248716067,0.5158203394767683,"['MDH1', 'GOT1']",0.9995549766482514,0,0,2
207,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6169033430704975,0.946218487394958,0.4570641445499907,"['SMAD3', 'CFL1', 'BANF1', 'ADCY1', 'ADCY7', 'HRAS', 'EMD', 'RHOA']",0.9995549766482514,0,0,8
208,Modulators of TCR signaling and T cell activation WP5072,0.6169033430704975,0.946218487394958,0.4570641445499907,"['CDKN1B', 'NDUFB10', 'DGKA', 'ELOB', 'IKBKG', 'RNF7', 'DGKZ', 'MEF2D']",0.9995549766482514,0,0,8
209,NRF2 pathway WP2884,0.6221134692615339,0.9460598398651496,0.44903100845007127,"['EGR1', 'ABCC4', 'G6PD', 'HSP90AB1', 'MGST3', 'SLC2A12', 'TGFA', 'SLC39A10', 'SLC2A3', 'TXN', 'CES4A', 'GSTA4', 'PRDX1', 'SQSTM1', 'CES2', 'SLC39A3']",0.9995549766482514,0,0,16
210,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6255936605677548,0.9408907288084666,0.44132876988529224,"['JUN', 'STAT1', 'STAT2', 'IKBKG', 'IFNAR1']",0.9995549766482514,0,0,5
211,Pregnane X receptor pathway WP2876,0.6277587777863085,0.9554269583627382,0.44484612120812234,"['ABCC4', 'PSMC5', 'DNAJC7']",0.9995549766482514,0,0,3
212,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6277587777863085,0.9554269583627382,0.44484612120812234,"['STAT1', 'STAT2', 'IFNAR1']",0.9995549766482514,0,0,3
213,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6331514863720954,0.9313626333210739,0.42567516609364486,"['MDC1', 'RIF1', 'KAT5', 'PARP1', 'PRKDC', 'RNF8', 'NABP2', 'BAX', 'TP53BP1']",0.9995549766482514,0,0,9
214,Melanoma WP4685,0.638245555391155,0.9291911096422375,0.41723671575757554,"['PAK1', 'GADD45B', 'GADD45A', 'CDK4', 'BAX', 'E2F3', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'CALM2']",0.9995549766482514,0,0,11
215,Notch Signaling WP268,0.6424605696986796,0.919911829537105,0.4070148364708993,"['NUMBL', 'JAG1', 'NOTCH4', 'PSEN2', 'DTX4', 'DLL3']",0.9995549766482514,0,0,6
216,Corticotropin-releasing hormone signaling pathway WP2355,0.6434973118750207,0.9276751127198831,0.40895391192173,"['PARP1', 'PRKCD', 'CAMK2A', 'ARRB2', 'RHOA', 'CRHR1', 'GNAO1', 'MAPK9', 'GNB2', 'GRK6', 'GNB1', 'CTNNB1', 'GNB5']",0.9995549766482514,0,0,13
217,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6443478685922029,0.9198529411764705,0.4042905729034743,"['EIF4A2', 'EIF4A1', 'MAPK9', 'CSNK2A1', 'PRKCD', 'RPS6', 'PIM2', 'EIF4B']",0.9995549766482514,0,0,8
218,Estrogen signaling pathway WP712,0.6446269340103514,0.919970631424376,0.4039439490353513,"['MAPK9', 'JUN', 'GNB1', 'IKBKG']",0.9995549766482514,0,0,4
219,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6446269340103514,0.919970631424376,0.4039439490353513,"['SMAD3', 'TGFA', 'CTNNB1', 'HRAS']",0.9995549766482514,0,0,4
220,DNA damage response WP707,0.6477863244365852,0.919793966151582,0.39936937384836796,"['CDKN1B', 'CCND2', 'GADD45B', 'PRKDC', 'GADD45A', 'CDK4', 'CYCS', 'BAX', 'RAD1', 'BBC3']",0.9995549766482514,0,0,10
221,Non-small cell lung cancer WP4255,0.6518970712391408,0.9197349042709867,0.39352568192077364,"['ALK', 'PRKCG', 'RXRB', 'GADD45B', 'GADD45A', 'CDK4', 'TGFA', 'CYCS', 'BAX', 'E2F3', 'JAK3', 'HRAS']",0.9995549766482514,0,0,12
222,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.6610367775191316,1.0351118445177852,0.428480202086128,['COX8A'],0.9995549766482514,0,0,1
223,Cytokines and Inflammatory Response WP530,0.6610367775191316,1.0351118445177852,0.428480202086128,['HLA-DRB1'],0.9995549766482514,0,0,1
224,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.6610367775191316,1.0351118445177852,0.428480202086128,['BCL2L1'],0.9995549766482514,0,0,1
225,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6610367775191316,1.0351118445177852,0.428480202086128,['HIF1AN'],0.9995549766482514,0,0,1
226,Mitochondrial fatty acid synthesis pathway WP4317,0.6610367775191316,1.0351118445177852,0.428480202086128,['MECR'],0.9995549766482514,0,0,1
227,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6610367775191316,1.0351118445177852,0.428480202086128,['MOCS2'],0.9995549766482514,0,0,1
228,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.6610367775191316,1.0351118445177852,0.428480202086128,['HLA-DRB1'],0.9995549766482514,0,0,1
229,PTF1A related regulatory pathway WP4147,0.6610367775191316,1.0351118445177852,0.428480202086128,['CTNNB1'],0.9995549766482514,0,0,1
230,The alternative pathway of fetal androgen synthesis WP4524,0.6610367775191316,1.0351118445177852,0.428480202086128,['CYB5A'],0.9995549766482514,0,0,1
231,Vitamin D Metabolism WP1531,0.6610367775191316,1.0351118445177852,0.428480202086128,['RXRB'],0.9995549766482514,0,0,1
232,Cysteine and methionine catabolism WP4504,0.6615746655856388,0.9200293470286134,0.3800939585685721,"['GOT1', 'GSS']",0.9995549766482514,0,0,2
233,Disorders of Folate Metabolism and Transport WP4259,0.6615746655856388,0.9200293470286134,0.3800939585685721,"['ATIC', 'MTHFD1']",0.9995549766482514,0,0,2
234,FOXA2 pathway WP5066,0.6615746655856388,0.9200293470286134,0.3800939585685721,"['ABCC4', 'SLC27A5']",0.9995549766482514,0,0,2
235,Glycolysis in senescence WP5049,0.6615746655856388,0.9200293470286134,0.3800939585685721,"['G6PD', 'PGK1']",0.9995549766482514,0,0,2
236,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6615746655856388,0.9200293470286134,0.3800939585685721,"['CENPE', 'ANAPC11']",0.9995549766482514,0,0,2
237,Triacylglyceride synthesis WP325,0.6705210241887072,0.8871035386631717,0.3545754802458383,"['DGAT2', 'LPL', 'AGPAT1']",0.9995549766482514,0,0,3
238,ATM Signaling Pathway WP2516,0.6725978636511459,0.8869791119974808,0.35178270647318494,"['MDC1', 'MAPK9', 'JUN', 'GADD45A', 'TP53BP1', 'IKBKG']",0.9995549766482514,0,0,6
239,Ferroptosis WP4313,0.6725978636511459,0.8869791119974808,0.35178270647318494,"['MAP1LC3A', 'GPX4', 'GSS', 'LPCAT3', 'VDAC2', 'ACSL3']",0.9995549766482514,0,0,6
240,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6725978636511459,0.8869791119974808,0.35178270647318494,"['ACTN2', 'CAMK2A', 'CYCS', 'CALM1', 'CALM2', 'CNGB1']",0.9995549766482514,0,0,6
241,Leptin signaling pathway WP2034,0.6733971662549534,0.9029321194269648,0.3570374009479386,"['CDC42', 'KHDRBS1', 'GSK3A', 'STAT1', 'RPS6', 'BAX', 'RAC1', 'IKBKG', 'HRAS', 'RHOA', 'SH2B1', 'BCL2L1']",0.9995549766482514,0,0,12
242,Cannabinoid receptor signaling WP3869,0.6808262037466969,0.8714738387819769,0.3350365598425981,"['MAPK9', 'PRKAR1A', 'ADCY1', 'ADCY7']",0.9995549766482514,0,0,4
243,Prader-Willi and Angelman Syndrome WP3998,0.6846307843536472,0.8779526243693829,0.33263481589570115,"['CCND2', 'SNRPN', 'BDNF', 'CDK4', 'FEZ1', 'NDN', 'BBS4']",0.9995549766482514,0,0,7
244,Vitamin D Receptor Pathway WP2877,0.6847699226898818,0.8965930018416206,0.3395150026932445,"['CDKN2D', 'CEBPA', 'G6PD', 'CDKN1B', 'GADD45A', 'TPM1', 'HILPDA', 'CREG2', 'S100A6', 'CLPTM1L', 'MXD1', 'HLA-DRB1', 'CD200']",0.9995549766482514,0,0,13
245,Autophagy WP4923,0.6911251571380393,0.8623301505692251,0.31857437603815086,"['ATG3', 'ATG101', 'ATG9A', 'PRKAG1', 'WIPI2']",0.9995549766482514,0,0,5
246,Melatonin metabolism and effects WP3298,0.6911251571380393,0.8623301505692251,0.31857437603815086,"['SULT1A1', 'CAMK2A', 'CRY2', 'CALM1', 'CALM2']",0.9995549766482514,0,0,5
247,miRNA regulation of DNA damage response WP1530,0.6939577255788912,0.8804972367040846,0.3216845889072832,"['CDKN1B', 'CCND2', 'GADD45B', 'PRKDC', 'GADD45A', 'CDK4', 'CYCS', 'BAX', 'RAD1', 'BBC3']",0.9995549766482514,0,0,10
248,Alzheimer's disease WP2059,0.6941144333491482,0.8867294340416579,0.3237612698904142,"['PSENEN', 'BACE1', 'ATP5MD', 'PSEN2', 'CHP1', 'LPL', 'CYCS', 'CALM3', 'MAPT', 'CALM1', 'CALM2', 'SNCA']",0.9995549766482514,0,0,12
249,IL-3 signaling pathway WP286,0.7010560187979796,0.8563176163571411,0.30413617197669307,"['JUN', 'YWHAQ', 'YWHAB', 'INPP5D', 'HRAS', 'BCL2L1']",0.9995549766482514,0,0,6
250,Netrin-UNC5B signaling pathway WP4747,0.7010560187979796,0.8563176163571411,0.30413617197669307,"['JUN', 'INPP5D', 'AGAP2', 'RAC1', 'RHOA', 'RGMA']",0.9995549766482514,0,0,6
251,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7059827760822535,0.866152911894763,0.301563642026245,"['WNT10B', 'PORCN', 'WNT10A', 'JUN', 'CCND2', 'CSNK2A1', 'CSNK2B', 'CTNNB1', 'ELAVL1']",0.9995549766482514,0,0,9
252,Cancer immunotherapy by PD-1 blockade WP4585,0.7094383874159321,0.8279530447542186,0.284221067119358,"['JUN', 'HLA-DRB1']",0.9995549766482514,0,0,2
253,Canonical and non-canonical TGF-B signaling WP3874,0.7094383874159321,0.8279530447542186,0.284221067119358,"['MAPK9', 'SMAD3']",0.9995549766482514,0,0,2
254,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7094383874159321,0.8279530447542186,0.284221067119358,"['CCKBR', 'CCK']",0.9995549766482514,0,0,2
255,Ganglio Sphingolipid Metabolism WP1423,0.7094383874159321,0.8279530447542186,0.284221067119358,"['ST3GAL5', 'FUT1']",0.9995549766482514,0,0,2
256,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7094383874159321,0.8279530447542186,0.284221067119358,"['ADCY1', 'ADCY7']",0.9995549766482514,0,0,2
257,Immune response to tuberculosis WP4197,0.7095557898864121,0.8278899082568807,0.2840624002576599,"['STAT1', 'STAT2', 'IFNAR1']",0.9995549766482514,0,0,3
258,Monoamine Transport WP727,0.7095557898864121,0.8278899082568807,0.2840624002576599,"['PPP2CB', 'FBXO32', 'STX1A']",0.9995549766482514,0,0,3
259,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7143555135194605,0.827826725403818,0.27845981944408293,"['RAB3A', 'RAB4B', 'HSPB8', 'NDRG1']",0.9995549766482514,0,0,4
260,Neovascularisation processes WP4331,0.7143555135194605,0.827826725403818,0.27845981944408293,"['MAPK9', 'SMAD3', 'JAG1', 'NOTCH4']",0.9995549766482514,0,0,4
261,Oxidative Stress WP408,0.7143555135194605,0.827826725403818,0.27845981944408293,"['CAT', 'NOX4', 'TXN2', 'SOD1']",0.9995549766482514,0,0,4
262,Peptide GPCRs WP24,0.7143555135194605,0.827826725403818,0.27845981944408293,"['NPY5R', 'CCKBR', 'OPRL1', 'SSTR1']",0.9995549766482514,0,0,4
263,ACE Inhibitor Pathway WP554,0.7270011427299173,0.828016134946828,0.2639940903748072,['MAS1'],0.9995549766482514,0,0,1
264,Benzo(a)pyrene metabolism WP696,0.7270011427299173,0.828016134946828,0.2639940903748072,['AKR1A1'],0.9995549766482514,0,0,1
265,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7270011427299173,0.828016134946828,0.2639940903748072,['CTNNB1'],0.9995549766482514,0,0,1
266,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.7270011427299173,0.828016134946828,0.2639940903748072,['CYB5A'],0.9995549766482514,0,0,1
267,Drug Induction of Bile Acid Pathway WP2289,0.7270011427299173,0.828016134946828,0.2639940903748072,['ABCC4'],0.9995549766482514,0,0,1
268,exRNA mechanism of action and biogenesis WP2805,0.7270011427299173,0.828016134946828,0.2639940903748072,['AGO2'],0.9995549766482514,0,0,1
269,LDLRAD4 and what we know about it WP4904,0.7270011427299173,0.828016134946828,0.2639940903748072,['PMEPA1'],0.9995549766482514,0,0,1
270,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7270011427299173,0.828016134946828,0.2639940903748072,['BAX'],0.9995549766482514,0,0,1
271,miRNA Biogenesis WP2338,0.7270011427299173,0.828016134946828,0.2639940903748072,['RAN'],0.9995549766482514,0,0,1
272,Nephrogenesis WP5052,0.7270011427299173,0.828016134946828,0.2639940903748072,['JAG1'],0.9995549766482514,0,0,1
273,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.7270011427299173,0.828016134946828,0.2639940903748072,['IKBKG'],0.9995549766482514,0,0,1
274,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7270011427299173,0.828016134946828,0.2639940903748072,['IL12RB2'],0.9995549766482514,0,0,1
275,Tamoxifen metabolism WP691,0.7270011427299173,0.828016134946828,0.2639940903748072,['SULT1A1'],0.9995549766482514,0,0,1
276,Complement system WP2806,0.7277963999859484,0.8277002204261572,0.2629884523813563,"['FKBP2', 'RPS19', 'CD59', 'TXN', 'CALR', 'ARRB2']",0.9995549766482514,0,0,6
277,Glycogen Synthesis and Degradation WP500,0.7277963999859484,0.8277002204261572,0.2629884523813563,"['PPP2CB', 'GSK3A', 'PPP2R5A', 'CALM3', 'CALM1', 'CALM2']",0.9995549766482514,0,0,6
278,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7277963999859484,0.8277002204261572,0.2629884523813563,"['SMAD3', 'STAT1', 'STAT2', 'TRAF5', 'RAE1', 'IFNAR1']",0.9995549766482514,0,0,6
279,Wnt signaling WP428,0.741130145192513,0.853670086819258,0.25574166045075986,"['PRKCG', 'WNT10B', 'WNT10A', 'JUN', 'CSNK2A1', 'CAMK2A', 'RHOA', 'MAPK9', 'PORCN', 'CCND2', 'CSNK2B', 'CTNNB1', 'RAC1']",0.9995549766482514,0,0,13
280,Genotoxicity pathway WP4286,0.7420599536640176,0.8275735294117647,0.24688607094573958,"['COIL', 'CENPE', 'RPS27', 'GADD45A', 'BLOC1S2', 'B3GNT2', 'TRIAP1', 'DUSP14']",0.9995549766482514,0,0,8
281,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7449253777481676,0.7760779816513761,0.22853263761220188,"['CCND2', 'CTNNB1', 'GTPBP4']",0.9995549766482514,0,0,3
282,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7449253777481676,0.7760779816513761,0.22853263761220188,"['RPS6', 'PRKAG1', 'PDHB']",0.9995549766482514,0,0,3
283,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7449253777481676,0.7760779816513761,0.22853263761220188,"['BAX', 'BBC3', 'BCL2L1']",0.9995549766482514,0,0,3
284,Trans-sulfuration and one-carbon metabolism WP2525,0.7452183628495448,0.788336479966436,0.23183241460923198,"['AHCYL1', 'MTHFD1', 'GSS', 'MAT2B']",0.9995549766482514,0,0,4
285,Tryptophan metabolism WP465,0.7452183628495448,0.788336479966436,0.23183241460923198,"['ECHS1', 'WARS', 'AFMID', 'CAT']",0.9995549766482514,0,0,4
286,Hepatitis B infection WP4666,0.7473466184789062,0.8707144523050611,0.25357485029593224,"['PRKCG', 'JUN', 'SMAD3', 'EGR3', 'YWHAB', 'STAT1', 'STAT2', 'YWHAZ', 'DDB1', 'CREB3', 'MAPK9', 'YWHAQ', 'STAT4', 'CYCS', 'BAX', 'IKBKG', 'HRAS', 'JAK3', 'IFNAR1', 'ATF4']",0.9995549766482514,0,0,20
287,IL-5 signaling pathway WP127,0.7483491269059772,0.7958558151360208,0.2307071903841534,"['GSK3A', 'JUN', 'STAT1', 'RPS6', 'MAPT']",0.9995549766482514,0,0,5
288,22q11.2 copy number variation syndrome WP4657,0.7487599094353256,0.8516732411461269,0.2464204911494168,"['RANBP1', 'NPRL2', 'EMC10', 'RBX1', 'PPP1CB', 'CDC42', 'CYP26B1', 'MRPL40', 'HIRIP3', 'PI4KA', 'HIST1H4C', 'SNAP29', 'RAN', 'DGCR2']",0.9995549766482514,0,0,14
289,Circadian rhythm related genes WP3594,0.7504431999047677,0.8812476489788984,0.25299854530885835,"['PRKDC', 'CRTC1', 'SUV39H1', 'OPRL1', 'ADCY1', 'TNFRSF11A', 'PPP1CB', 'MAPK9', 'UBC', 'RPS27A', 'SKP1', 'PRKCG', 'EGR1', 'PRMT5', 'JUN', 'EGR3', 'FBXW11', 'USP2', 'CARTPT', 'CDK4', 'THRAP3', 'CRY2', 'KLF9', 'ATF5', 'UBA52', 'ATF4']",0.9995549766482514,0,0,26
290,"GPCRs, Class B Secretin-like WP334",0.7514943282221083,0.7526178883478957,0.21501662157565,"['GLP2R', 'CRHR1']",0.9995549766482514,0,0,2
291,IL-9 signaling pathway WP22,0.7514943282221083,0.7526178883478957,0.21501662157565,"['STAT1', 'JAK3']",0.9995549766482514,0,0,2
292,Transcription co-factors SKI and SKIL protein partners WP4533,0.7514943282221083,0.7526178883478957,0.21501662157565,"['PRMT5', 'ING2']",0.9995549766482514,0,0,2
293,Tryptophan catabolism leading to NAD+ production WP4210,0.7514943282221083,0.7526178883478957,0.21501662157565,"['AFMID', 'NMNAT2']",0.9995549766482514,0,0,2
294,Integrated Cancer Pathway WP1971,0.7528064725572282,0.8009291081036239,0.22742149176148588,"['CDKN1B', 'SMAD3', 'STAT1', 'CDK4', 'BAX', 'BBC3']",0.9995549766482514,0,0,6
295,EGF/EGFR signaling pathway WP437,0.7627865367039681,0.8740048022241881,0.23666044661985172,"['NDUFA13', 'PTPRR', 'STXBP1', 'CAMK2A', 'PEBP1', 'NEDD8', 'CDC42', 'MAPK9', 'PAK1', 'INPP5D', 'CFL1', 'STMN1', 'AP2S1', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'RALBP1', 'MEF2C', 'JUN', 'CAV2', 'STAT1', 'PRKCD', 'RAB5A', 'PTPN5', 'BCAR1']",0.9995549766482514,0,0,26
296,MET in type 1 papillary renal cell carcinoma WP4205,0.7688254028027379,0.8094488063066665,0.21279711350652955,"['ALK', 'CDC42', 'PAK1', 'JUN', 'PRCC', 'RPL11', 'RAC1', 'JAK3', 'HRAS']",0.9995549766482514,0,0,9
297,Oncostatin M Signaling Pathway WP2374,0.7688254028027379,0.8094488063066665,0.21279711350652955,"['MAPK9', 'EGR1', 'CEBPB', 'CDKN1B', 'STAT1', 'PRKCD', 'RPS6', 'JAK3', 'HRAS']",0.9995549766482514,0,0,9
298,Endothelin Pathways WP2197,0.7734649054910616,0.7524362568415431,0.19328204921795075,"['RIIAD1', 'GNB5', 'CALM1', 'CALM2']",0.9995549766482514,0,0,4
299,Oxysterols derived from cholesterol WP4545,0.7734649054910616,0.7524362568415431,0.19328204921795075,"['ACOT8', 'ACOT7', 'CYP46A1', 'SLC27A5']",0.9995549766482514,0,0,4
300,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7738373855105519,0.7663116660545967,0.1964773483162276,"['MAPK9', 'JUN', 'TRAF5', 'CTNNB1', 'RAC1']",0.9995549766482514,0,0,5
301,TNF-alpha signaling pathway WP231,0.774798629534213,0.827255985267035,0.2110761153215911,"['JUN', 'CSNK2A1', 'FBXW11', 'TXN', 'MAPK9', 'CDC37', 'MADD', 'BAX', 'RAC1', 'IKBKG', 'HRAS', 'SKP1', 'BCL2L1']",0.9995549766482514,0,0,13
302,1q21.1 copy number variation syndrome WP4905,0.7767639123518737,0.7303615758229898,0.18450307937868288,"['PYGO2', 'PRKAG1', 'CTNNB1']",0.9995549766482514,0,0,3
303,Genes controlling nephrogenesis WP4823,0.7767639123518737,0.7303615758229898,0.18450307937868288,"['ROBO2', 'NPHS1', 'CTNNB1']",0.9995549766482514,0,0,3
304,NRF2-ARE regulation WP4357,0.7767639123518737,0.7303615758229898,0.18450307937868288,"['CEBPB', 'PGAM5', 'RBX1']",0.9995549766482514,0,0,3
305,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7767639123518737,0.7303615758229898,0.18450307937868288,"['GSK3A', 'CALM1', 'CALM2']",0.9995549766482514,0,0,3
306,Aspirin and miRNAs WP4707,0.780132157150447,0.6899523285661899,0.1713096031375369,['ABCC4'],0.9995549766482514,0,0,1
307,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.780132157150447,0.6899523285661899,0.1713096031375369,['BATF3'],0.9995549766482514,0,0,1
308,Estrogen metabolism WP697,0.780132157150447,0.6899523285661899,0.1713096031375369,['SULT1A1'],0.9995549766482514,0,0,1
309,Glial Cell Differentiation WP2276,0.780132157150447,0.6899523285661899,0.1713096031375369,['GAP43'],0.9995549766482514,0,0,1
310,HIF1A and PPARG regulation of glycolysis WP2456,0.780132157150447,0.6899523285661899,0.1713096031375369,['TPI1'],0.9995549766482514,0,0,1
311,Insulin signaling in adipocytes (diabetic condition) WP3635,0.780132157150447,0.6899523285661899,0.1713096031375369,['RPS6'],0.9995549766482514,0,0,1
312,Insulin signaling in adipocytes (normal condition) WP3634,0.780132157150447,0.6899523285661899,0.1713096031375369,['RPS6'],0.9995549766482514,0,0,1
313,Ketogenesis and Ketolysis WP4742,0.780132157150447,0.6899523285661899,0.1713096031375369,['OXCT1'],0.9995549766482514,0,0,1
314,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.780132157150447,0.6899523285661899,0.1713096031375369,['LPL'],0.9995549766482514,0,0,1
315,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.780132157150447,0.6899523285661899,0.1713096031375369,['MAT2B'],0.9995549766482514,0,0,1
316,Methylation Pathways WP704,0.780132157150447,0.6899523285661899,0.1713096031375369,['MAT2B'],0.9995549766482514,0,0,1
317,Mevalonate pathway WP3963,0.780132157150447,0.6899523285661899,0.1713096031375369,['PMVK'],0.9995549766482514,0,0,1
318,NAD Biosynthesis II (from tryptophan) WP2485,0.780132157150447,0.6899523285661899,0.1713096031375369,['AFMID'],0.9995549766482514,0,0,1
319,Pentose Phosphate Metabolism WP134,0.780132157150447,0.6899523285661899,0.1713096031375369,['G6PD'],0.9995549766482514,0,0,1
320,Urea cycle and related diseases WP4571,0.780132157150447,0.6899523285661899,0.1713096031375369,['ASS1'],0.9995549766482514,0,0,1
321,Valproic acid pathway WP3871,0.780132157150447,0.6899523285661899,0.1713096031375369,['IVD'],0.9995549766482514,0,0,1
322,Differentiation of white and brown adipocyte WP2895,0.7881899522316949,0.6898385913426266,0.1641927339398499,"['CEBPA', 'CEBPB']",0.9995549766482514,0,0,2
323,Eicosanoid Synthesis WP167,0.7881899522316949,0.6898385913426266,0.1641927339398499,"['PTGES2', 'PLA2G4A']",0.9995549766482514,0,0,2
324,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7881899522316949,0.6898385913426266,0.1641927339398499,"['CTNNB1', 'RHOA']",0.9995549766482514,0,0,2
325,MAPK pathway in congenital thyroid cancer WP4928,0.7881899522316949,0.6898385913426266,0.1641927339398499,"['ALK', 'JUN']",0.9995549766482514,0,0,2
326,Pyrimidine metabolism and related diseases WP4225,0.7881899522316949,0.6898385913426266,0.1641927339398499,"['RRM2', 'TK2']",0.9995549766482514,0,0,2
327,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7972974985958023,0.7388778133361313,0.16737606762485444,"['MAPK9', 'PAK1', 'YWHAQ', 'CTNNB1', 'ACTG1']",0.9995549766482514,0,0,5
328,Alpha 6 Beta 4 signaling pathway WP244,0.7991816062592858,0.7196577922492499,0.16132357660686028,"['PRKCD', 'RAC1', 'HRAS', 'RHOA']",0.9995549766482514,0,0,4
329,GABA receptor Signaling WP4159,0.7991816062592858,0.7196577922492499,0.16132357660686028,"['GABBR1', 'AP2S1', 'AP2A2', 'AP2M1']",0.9995549766482514,0,0,4
330,Ebola Virus Pathway on Host WP4217,0.8005720078074358,0.8161726191630939,0.18154029386772608,"['CAV2', 'STAT1', 'CLTA', 'ACTN4', 'EIF2S1', 'RHOA', 'ACTG1', 'RHOB', 'CDC42', 'PAK1', 'VPS11', 'RAC1', 'RAB5A', 'HLA-DRB1', 'CTSB']",0.9995549766482514,0,0,15
331,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8052558147049199,0.6897247706422018,0.14939112278741815,"['BDNF', 'GRK6', 'RPS6']",0.9995549766482514,0,0,3
332,Glycerolipids and Glycerophospholipids WP4722,0.8052558147049199,0.6897247706422018,0.14939112278741815,"['DGAT2', 'CDIPT', 'DGKZ']",0.9995549766482514,0,0,3
333,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8052558147049199,0.6897247706422018,0.14939112278741815,"['SHISA5', 'BAX', 'BBC3']",0.9995549766482514,0,0,3
334,Small cell lung cancer WP4658,0.8052977015423404,0.8024188450015117,0.17375838804675384,"['CDKN1B', 'GADD45B', 'GADD45A', 'CKS1B', 'RXRB', 'CDK4', 'TRAF5', 'CYCS', 'BAX', 'E2F3', 'IKBKG', 'SKP1', 'BCL2L1']",0.9995549766482514,0,0,13
335,Prolactin Signaling Pathway WP2037,0.8084003752660287,0.78040179377178,0.1659897674737174,"['MAPK9', 'PAK1', 'JUN', 'STAT1', 'RPS6', 'AGAP2', 'RAC1', 'PPIB', 'HRAS', 'YWHAZ']",0.9995549766482514,0,0,10
336,Nuclear Receptors Meta-Pathway WP2882,0.8124478486036817,0.8576049287639584,0.17812759092227046,"['CDKN1B', 'HSP90AB1', 'MGST3', 'TGFA', 'SLC2A3', 'TXN', 'SULT1A1', 'SEC14L1', 'PRDX1', 'CAP2', 'SLC39A3', 'EGR1', 'ABCC4', 'JUN', 'G6PD', 'GADD45B', 'PLK2', 'PTGES3', 'SLC2A12', 'SLC39A10', 'CES4A', 'SLC7A5', 'PSMC5', 'GSTA4', 'DNAJC7', 'ETNK2', 'CDK4', 'ACOX1', 'CDC37', 'BAX', 'SQSTM1', 'CES2', 'SLC27A5']",0.9995549766482514,0,0,33
337,Wnt signaling pathway and pluripotency WP399,0.815640708572061,0.7877130233536713,0.1605212068520057,"['PRKCG', 'WNT10B', 'MAPK9', 'PPP2CB', 'WNT10A', 'JUN', 'CCND2', 'CTNND1', 'PRKCD', 'CTNNB1', 'RHOA', 'PAFAH1B1']",0.9995549766482514,0,0,12
338,Wnt Signaling Pathway WP363,0.8180438827062143,0.742487207757329,0.14912060919252348,"['PRKCG', 'MAPK9', 'GSK3A', 'CTNNB1', 'ARRB2', 'RAC1', 'RHOA']",0.9995549766482514,0,0,7
339,Nephrotic syndrome WP4758,0.8187974024773487,0.7133359504603188,0.14260912280020085,"['INF2', 'NPHS1', 'ARHGDIA', 'E2F3', 'ACTN4']",0.9995549766482514,0,0,5
340,ERK Pathway in Huntington's Disease WP3853,0.820018459205186,0.6367176477227835,0.12634288175918612,"['BDNF', 'HRAS']",0.9995549766482514,0,0,2
341,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.820018459205186,0.6367176477227835,0.12634288175918612,"['SUV39H1', 'CDC37']",0.9995549766482514,0,0,2
342,Prion disease pathway WP3995,0.8224820775400227,0.6896108663729809,0.13476967706058607,"['PDIA3', 'MEF2C', 'HSPA5', 'HSP90B1']",0.9995549766482514,0,0,4
343,Canonical NF-KB pathway WP4562,0.8229258048076324,0.5913353240085913,0.11524488862062819,['IKBKG'],0.9995549766482514,0,0,1
344,Farnesoid X receptor pathway WP2879,0.8229258048076324,0.5913353240085913,0.11524488862062819,['SLC27A5'],0.9995549766482514,0,0,1
345,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.8229258048076324,0.5913353240085913,0.11524488862062819,['CEBPB'],0.9995549766482514,0,0,1
346,Heme Biosynthesis WP561,0.8229258048076324,0.5913353240085913,0.11524488862062819,['ALAD'],0.9995549766482514,0,0,1
347,Leptin and adiponectin WP3934,0.8229258048076324,0.5913353240085913,0.11524488862062819,['PRKAG1'],0.9995549766482514,0,0,1
348,NLR Proteins WP288,0.8229258048076324,0.5913353240085913,0.11524488862062819,['IKBKG'],0.9995549766482514,0,0,1
349,Vitamin B12 Disorders WP4271,0.8229258048076324,0.5913353240085913,0.11524488862062819,['MMAA'],0.9995549766482514,0,0,1
350,TGF-beta Signaling Pathway WP366,0.8265642775456066,0.8088159794641425,0.15406132173279014,"['MEF2C', 'JUN', 'UBE2I', 'SMAD3', 'CITED1', 'RHOA', 'RBX1', 'SMAD7', 'CDC42', 'MAPK9', 'KLF6', 'SUMO1', 'SNIP1', 'STRAP', 'RAC1', 'E2F5', 'BCAR1', 'SKP1']",0.9995549766482514,0,0,18
351,7-oxo-C and 7beta-HC pathways WP5064,0.8306182243425587,0.6533655239014968,0.1212548452275412,"['ACOT8', 'ACOT7', 'SLC27A5']",0.9995549766482514,0,0,3
352,Nanoparticle triggered autophagic cell death WP2509,0.8306182243425587,0.6533655239014968,0.1212548452275412,"['ATG3', 'MAP1LC3A', 'CHAF1A']",0.9995549766482514,0,0,3
353,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8356684866563133,0.7352941176470589,0.13200242029767612,"['CACNB3', 'SGCB', 'ACTN2', 'CTNNB1', 'ACTN4', 'EMD', 'CACNG3', 'ACTG1']",0.9995549766482514,0,0,8
354,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8368049913518599,0.7444280985656492,0.13263045218260516,"['WNT10B', 'PORCN', 'WNT10A', 'JUN', 'CCND2', 'HNRNPK', 'CSNK2A1', 'CSNK2B', 'CTNNB1']",0.9995549766482514,0,0,9
355,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8384209328032232,0.6894968784428939,0.12151348110780984,"['JUN', 'RRM2', 'SMAD3', 'RAC1', 'BCL2L1']",0.9995549766482514,0,0,5
356,Osteoblast differentiation WP4787,0.8452234356232141,0.767824256774533,0.12911292410155537,"['PRKCG', 'WNT10B', 'WNT10A', 'JAG1', 'PRKDC', 'STAT1', 'NOTCH4', 'PRKCD', 'PIK3C2G', 'DLL3', 'MAPK9', 'CTNNB1', 'MAPK6']",0.9995549766482514,0,0,13
357,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['ACOX1', 'PLA2G4A']",0.9995549766482514,0,0,2
358,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['RBBP4', 'THRAP3']",0.9995549766482514,0,0,2
359,Kallmann's Syndrome WP5074,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['CHD7', 'ANOS1']",0.9995549766482514,0,0,2
360,Microglia Pathogen Phagocytosis Pathway WP3937,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['RAC3', 'RAC1']",0.9995549766482514,0,0,2
361,Proteoglycan biosynthesis WP4784,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['CANT1', 'B4GALT7']",0.9995549766482514,0,0,2
362,Transcription factor regulation in adipogenesis WP3599,0.8474840713113958,0.5911854103343465,0.09783127407872283,"['CEBPA', 'CEBPB']",0.9995549766482514,0,0,2
363,Acute viral myocarditis WP4298,0.8507379328593208,0.7192455242966752,0.1162668660071798,"['PARP1', 'SGCB', 'STAT1', 'RAC3', 'CYCS', 'BAX', 'EIF4G2', 'BCL2L1']",0.9995549766482514,0,0,8
364,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8507379328593208,0.7192455242966752,0.1162668660071798,"['MAPK9', 'PAK1', 'STMN1', 'CTNNB1', 'BAX', 'RAC1', 'IKBKG', 'HRAS']",0.9995549766482514,0,0,8
365,IL-1 signaling pathway WP195,0.8512016798487692,0.7061428276906805,0.11376397836908206,"['MAPK9', 'JUN', 'TOLLIP', 'UBE2N', 'IKBKG', 'UBE2V1', 'SQSTM1']",0.9995549766482514,0,0,7
366,Apoptosis Modulation and Signaling WP1772,0.8520561398486683,0.7383974561126879,0.11821954637338825,"['JUN', 'CAPNS1', 'BNIP3', 'TOLLIP', 'MADD', 'CYCS', 'BAX', 'BCL2L2', 'BBC3', 'BCL2L1']",0.9995549766482514,0,0,10
367,16p11.2 distal deletion syndrome WP4950,0.8530869818901216,0.6206422018348624,0.0986161761388982,"['CD81', 'RAB5A', 'SH2B1']",0.9995549766482514,0,0,3
368,MAPK Signaling Pathway WP382,0.8550548562336875,0.8310851169736188,0.13013932988576724,"['PPP5D1', 'PTPRR', 'RASGRF2', 'ARRB2', 'CACNA1G', 'CDC42', 'MAPK9', 'PAK1', 'STMN1', 'RAC3', 'RAC1', 'IKBKG', 'HRAS', 'CACNG3', 'FGF22', 'PRKCG', 'HSPA8', 'MEF2C', 'JUN', 'DUSP2', 'DUSP3', 'GADD45A', 'BDNF', 'PRKCD', 'PLA2G4C', 'PLA2G4A', 'DUSP7', 'CACNB3', 'MRAS', 'DDIT3', 'MAPT', 'PTPN5', 'ATF4']",0.9995549766482514,0,0,33
369,15q11.2 copy number variation syndrome WP4940,0.8573927644342355,0.5173725705903923,0.07960251109215075,['FMR1'],0.9995549766482514,0,0,1
370,Autosomal recessive Osteopetrosis pathways WP4788,0.8573927644342355,0.5173725705903923,0.07960251109215075,['TNFRSF11A'],0.9995549766482514,0,0,1
371,Biotin Metabolism (including IEMs) WP5031,0.8573927644342355,0.5173725705903923,0.07960251109215075,['MCCC2'],0.9995549766482514,0,0,1
372,Cancer immunotherapy by CTLA4 blockade WP4582,0.8573927644342355,0.5173725705903923,0.07960251109215075,['HLA-DRB1'],0.9995549766482514,0,0,1
373,Cytosine methylation WP3585,0.8573927644342355,0.5173725705903923,0.07960251109215075,['IDH2'],0.9995549766482514,0,0,1
374,Matrix Metalloproteinases WP129,0.8573927644342355,0.5173725705903923,0.07960251109215075,['MMP28'],0.9995549766482514,0,0,1
375,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8573927644342355,0.5173725705903923,0.07960251109215075,['JUN'],0.9995549766482514,0,0,1
376,Serotonin and anxiety-related events WP3944,0.8573927644342355,0.5173725705903923,0.07960251109215075,['CRHR1'],0.9995549766482514,0,0,1
377,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8623781336760383,0.6364509205918898,0.09423383619510052,"['PRKCG', 'PRKCD', 'ARRB2', 'HRAS']",0.9995549766482514,0,0,4
378,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8623781336760383,0.6364509205918898,0.09423383619510052,"['MAPK9', 'STAT1', 'RPS6', 'STAT4']",0.9995549766482514,0,0,4
379,Ciliopathies WP4803,0.8641908559759899,0.807566659060679,0.11787375110066813,"['ARL6', 'ARL3', 'CFAP298', 'TCTN3', 'TMEM107', 'BBS4', 'PLK4', 'TUB', 'MKKS', 'IFT122', 'DCDC2', 'CFAP410', 'POMGNT1', 'LZTFL1', 'RSPH1', 'TMEM17', 'BBS12', 'TMEM216', 'IFT27', 'B9D1', 'CEP41', 'CCNQ', 'CLUAP1', 'CCNO', 'DNAL1', 'CNGB1']",0.9995549766482514,0,0,26
380,Pathways Regulating Hippo Signaling WP4540,0.8655437901129137,0.7335118192503591,0.10591713390763373,"['PRKCG', 'CDC42', 'SMAD3', 'GNAL', 'PRKAR1A', 'PRKCD', 'PRKAG1', 'CTNNB1', 'RAC1', 'CDH9', 'RHOA']",0.9995549766482514,0,0,11
381,Breast cancer pathway WP4262,0.8659166846798119,0.7720601051475268,0.1111508545255068,"['WNT10B', 'WNT10A', 'JUN', 'CSNK2A1', 'GADD45B', 'PARP1', 'GADD45A', 'NOTCH4', 'DLL3', 'CDK4', 'CSNK2B', 'CTNNB1', 'BAX', 'E2F3', 'HRAS', 'FGF22', 'SKP1']",0.9995549766482514,0,0,17
382,Constitutive Androstane Receptor Pathway WP2875,0.8710790874954625,0.5517241379310345,0.07615034783631054,"['SULT1A1', 'DNAJC7']",0.9995549766482514,0,0,2
383,Hippo-Yap signaling pathway WP4537,0.8710790874954625,0.5517241379310345,0.07615034783631054,"['YWHAQ', 'NDRG1']",0.9995549766482514,0,0,2
384,Nanomaterial induced apoptosis WP2507,0.8710790874954625,0.5517241379310345,0.07615034783631054,"['BAX', 'CYCS']",0.9995549766482514,0,0,2
385,Purinergic signaling WP4900,0.8710790874954625,0.5517241379310345,0.07615034783631054,"['GNAO1', 'P2RX5']",0.9995549766482514,0,0,2
386,One-carbon metabolism WP241,0.8729057173556284,0.591035386631717,0.08033809693080175,"['ATIC', 'MTHFD1', 'MAT2B']",0.9995549766482514,0,0,3
387,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.876520052486331,0.7128086067341605,0.09394510713400694,"['CREB3', 'THRA', 'SECISBP2L', 'RPS6', 'CTNNB1', 'TTF2', 'TTF1', 'SLC16A2', 'HRAS', 'MGLL']",0.9995549766482514,0,0,10
388,Oxidative Damage WP3941,0.8792712810051929,0.6128242780225159,0.07884707734910326,"['CDC42', 'CDKN1B', 'GADD45A', 'CYCS']",0.9995549766482514,0,0,4
389,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.879292362462238,0.6731793201883712,0.08659632598345718,"['CDKN1B', 'INF2', 'JAG1', 'YWHAQ', 'NPHS1', 'CTNNB1', 'ACTN4']",0.9995549766482514,0,0,7
390,Glucocorticoid Receptor Pathway WP2880,0.8822809178796731,0.652983487373835,0.081782768445584,"['JUN', 'SEC14L1', 'GADD45B', 'ETNK2', 'PLK2', 'PTGES3']",0.9995549766482514,0,0,6
391,IL-4 signaling pathway WP395,0.8822809178796731,0.652983487373835,0.081782768445584,"['CEBPA', 'CEBPB', 'HRH1', 'STAT1', 'INPP5D', 'JAK3']",0.9995549766482514,0,0,6
392,Phosphodiesterases in neuronal function WP4222,0.8822809178796731,0.652983487373835,0.081782768445584,"['PDE10A', 'PDE1B', 'PDE4C', 'PPP1R1B', 'ADCY1', 'ADCY7']",0.9995549766482514,0,0,6
393,Dopaminergic Neurogenesis WP2855,0.8851527420778412,0.4598459845984598,0.05609893799793819,['NEUROD1'],0.9995549766482514,0,0,1
394,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.8851527420778412,0.4598459845984598,0.05609893799793819,['GABBR1'],0.9995549766482514,0,0,1
395,Hedgehog Signaling Pathway Netpath WP47,0.8851527420778412,0.4598459845984598,0.05609893799793819,['SAP18'],0.9995549766482514,0,0,1
396,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8851527420778412,0.4598459845984598,0.05609893799793819,['PMVK'],0.9995549766482514,0,0,1
397,Neuroinflammation WP4919,0.8851527420778412,0.4598459845984598,0.05609893799793819,['JUN'],0.9995549766482514,0,0,1
398,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8851527420778412,0.4598459845984598,0.05609893799793819,['ADAR'],0.9995549766482514,0,0,1
399,Aryl Hydrocarbon Receptor Netpath WP2586,0.8870244909735058,0.6266484158515007,0.07512429529193464,"['KLF6', 'CDKN1B', 'CDC37', 'LPL', 'HRAS']",0.9995549766482514,0,0,5
400,IL17 signaling pathway WP2112,0.890317583653468,0.5641201000834029,0.0655378058809972,"['CEBPB', 'IKBKG', 'IL17RE']",0.9995549766482514,0,0,3
401,Lung fibrosis WP3624,0.890317583653468,0.5641201000834029,0.0655378058809972,"['CEBPB', 'TGFA', 'SMAD7']",0.9995549766482514,0,0,3
402,Heart Development WP1591,0.8912694430733265,0.5171955245781364,0.059533596893792055,"['MEF2C', 'CTNNB1']",0.9995549766482514,0,0,2
403,NAD+ biosynthetic pathways WP3645,0.8912694430733265,0.5171955245781364,0.059533596893792055,"['PARP1', 'PARP2']",0.9995549766482514,0,0,2
404,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8912694430733265,0.5171955245781364,0.059533596893792055,"['ABCC4', 'JUN']",0.9995549766482514,0,0,2
405,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8912694430733265,0.5171955245781364,0.059533596893792055,"['PTGES2', 'HRAS']",0.9995549766482514,0,0,2
406,Toll-like Receptor Signaling related to MyD88 WP3858,0.8912694430733265,0.5171955245781364,0.059533596893792055,"['TOLLIP', 'IKBKG']",0.9995549766482514,0,0,2
407,Vitamin D in inflammatory diseases WP4482,0.8912694430733265,0.5171955245781364,0.059533596893792055,"['SMAD3', 'IKBKG']",0.9995549766482514,0,0,2
408,Fragile X Syndrome  WP4549,0.8941080199213383,0.7511573297551157,0.08407605098720772,"['EIF4A1', 'DUSP3', 'BDNF', 'FMR1', 'CAMK2A', 'AGAP2', 'CLTA', 'AKAP5', 'EEF1A1', 'SYNGAP1', 'ALDH5A1', 'PRKAR1A', 'CAMK4', 'AGO2', 'AP2S1', 'CAMK1', 'PTPN5', 'AP2M1']",0.9995549766482514,0,0,18
409,Folate Metabolism WP176,0.8943332272255822,0.5908852527795259,0.0659881953921615,"['GPX4', 'MTHFD1', 'CAT', 'SOD1']",0.9995549766482514,0,0,4
410,Target Of Rapamycin (TOR) Signaling WP1471,0.8943332272255822,0.5908852527795259,0.0659881953921615,"['CDC42', 'FKBP1A', 'PRKAG1', 'RAC1']",0.9995549766482514,0,0,4
411,T-cell receptor (TCR) signaling pathway WP69,0.8985816086180303,0.676451904109131,0.07233824410907078,"['CDC42', 'MAPK9', 'PAK1', 'JUN', 'DBNL', 'RIPK2', 'PRKCD', 'IKBKG', 'HRAS']",0.9995549766482514,0,0,9
412,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9001611560805665,0.6081635739128556,0.06396753832500914,"['MEF2C', 'THRA', 'STAT1', 'CALM1', 'CALM2']",0.9995549766482514,0,0,5
413,Endochondral Ossification WP474,0.9001611560805665,0.6081635739128556,0.06396753832500914,"['MEF2C', 'THRA', 'STAT1', 'CALM1', 'CALM2']",0.9995549766482514,0,0,5
414,One-carbon metabolism and related pathways WP3940,0.9001611560805665,0.6081635739128556,0.06396753832500914,"['AHCYL1', 'GPX4', 'ETNK2', 'GSS', 'SOD1']",0.9995549766482514,0,0,5
415,Development of ureteric collection system WP5053,0.9055591919193976,0.5395452732349422,0.05352431252343885,"['ROBO2', 'ANOS1', 'CTNNB1']",0.9995549766482514,0,0,3
416,Lipid Metabolism Pathway WP3965,0.9055591919193976,0.5395452732349422,0.05352431252343885,"['PRKAR1A', 'HILPDA', 'PRKAG1']",0.9995549766482514,0,0,3
417,Endoderm differentiation WP2853,0.9065848739391302,0.7206259268466213,0.07067223503470167,"['DUSP5', 'DUSP2', 'SMAD3', 'CRTC1', 'STAT1', 'SIAH2', 'CTR9', 'SLC2A12', 'RTF1', 'ELAVL1', 'NME1', 'TCEAL2', 'NABP2', 'CTNNB1', 'HPRT1']",0.9995549766482514,0,0,15
418,Hypertrophy Model WP516,0.9075104720615226,0.4138247158049138,0.04016176044592685,['DUSP14'],0.9995549766482514,0,0,1
419,Leptin Insulin Overlap WP3935,0.9075104720615226,0.4138247158049138,0.04016176044592685,['DGKZ'],0.9995549766482514,0,0,1
420,Mammalian disorder of sexual development WP4842,0.9075104720615226,0.4138247158049138,0.04016176044592685,['CTNNB1'],0.9995549766482514,0,0,1
421,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9075104720615226,0.4138247158049138,0.04016176044592685,['IKBKG'],0.9995549766482514,0,0,1
422,"NAD metabolism, sirtuins and aging WP3630",0.9075104720615226,0.4138247158049138,0.04016176044592685,['PARP1'],0.9995549766482514,0,0,1
423,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.9075104720615226,0.4138247158049138,0.04016176044592685,['JAK3'],0.9995549766482514,0,0,1
424,RAS and bradykinin pathways in COVID-19 WP4969,0.9075104720615226,0.4138247158049138,0.04016176044592685,['RHOA'],0.9995549766482514,0,0,1
425,Gastric Cancer Network 1 WP2361,0.9084863359017565,0.4867291010314617,0.04671403551616238,"['H3F3A', 'MCM4']",0.9995549766482514,0,0,2
426,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9084863359017565,0.4867291010314617,0.04671403551616238,"['ATG3', 'MAP1LC3A']",0.9995549766482514,0,0,2
427,Monoamine GPCRs WP58,0.9084863359017565,0.4867291010314617,0.04671403551616238,"['HRH1', 'HTR5A']",0.9995549766482514,0,0,2
428,TLR4 Signaling and Tolerance WP3851,0.9084863359017565,0.4867291010314617,0.04671403551616238,"['INPP5D', 'IKBKG']",0.9995549766482514,0,0,2
429,p53 transcriptional gene network WP4963,0.9170077891187741,0.605042920377771,0.05242050273320297,"['SIVA1', 'GADD45A', 'SESN2', 'BAX', 'ISG15', 'BBC3']",0.9995549766482514,0,0,6
430,Prostaglandin Synthesis and Regulation WP98,0.9188563450660778,0.5170183486238532,0.043752928724265075,"['ABCC4', 'S100A6', 'PLA2G4A']",0.9995549766482514,0,0,3
431,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9223158124641663,0.6156685198651934,0.04978762592359249,"['MAPK9', 'DUSP2', 'STMN1', 'MAPK6', 'JAK3', 'IFNAR1', 'IL12RB2']",0.9995549766482514,0,0,7
432,Splicing factor NOVA regulated synaptic proteins WP4148,0.9224956408161802,0.5742746970253397,0.04632824927924117,"['MAPK9', 'CAV2', 'APLP2', 'CLSTN1', 'MAP4']",0.9995549766482514,0,0,5
433,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9231221053470968,0.45964783565663975,0.0367689592990913,"['IKBKG', 'RHOA']",0.9995549766482514,0,0,2
434,Signal Transduction of S1P Receptor WP26,0.9231221053470968,0.45964783565663975,0.0367689592990913,"['ASAH1', 'MAPK6']",0.9995549766482514,0,0,2
435,miRNAs involved in DNA damage response WP1545,0.9255169491884145,0.37617095042837617,0.02911669747685661,['CDKN1B'],0.9995549766482514,0,0,1
436,Overview of nanoparticle effects WP3287,0.9255169491884145,0.37617095042837617,0.02911669747685661,['BAX'],0.9995549766482514,0,0,1
437,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9255169491884145,0.37617095042837617,0.02911669747685661,['CTNNB1'],0.9995549766482514,0,0,1
438,Serotonin and anxiety WP3947,0.9255169491884145,0.37617095042837617,0.02911669747685661,['FMR1'],0.9995549766482514,0,0,1
439,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.9255169491884145,0.37617095042837617,0.02911669747685661,['SMAD3'],0.9995549766482514,0,0,1
440,IL-6 signaling pathway WP364,0.9300446389766915,0.5335607029510682,0.03869526017056701,"['STAT1', 'PRKCD', 'RAC1', 'BCL2L1']",0.9995549766482514,0,0,4
441,PDGFR-beta pathway WP3972,0.930421212680863,0.49629357798165136,0.03579163996196303,"['JUN', 'STAT1', 'HRAS']",0.9995549766482514,0,0,3
442,Cardiac Progenitor Differentiation WP2406,0.9355290289900079,0.43541722979495695,0.029017555421698742,"['MESP1', 'MEF2C']",0.9995549766482514,0,0,2
443,Differentiation Pathway WP2848,0.9355290289900079,0.43541722979495695,0.029017555421698742,"['ALK', 'NT5E']",0.9995549766482514,0,0,2
444,Sphingolipid Metabolism (general overview) WP4725,0.9355290289900079,0.43541722979495695,0.029017555421698742,"['ASAH1', 'DEGS2']",0.9995549766482514,0,0,2
445,Toll-like Receptor Signaling Pathway WP75,0.9383174332404379,0.5904341891111461,0.03759115713763991,"['MAPK9', 'JUN', 'STAT1', 'TOLLIP', 'RAC1', 'IKBKG', 'IFNAR1']",0.9995549766482514,0,0,7
446,Omega-9 FA synthesis WP4724,0.9400187601019574,0.34479281261459477,0.021327313326672426,['ACSL3'],0.9995549766482514,0,0,1
447,Phytochemical activity on NRF2 transcriptional activation WP3,0.9400187601019574,0.34479281261459477,0.021327313326672426,['CEBPB'],0.9995549766482514,0,0,1
448,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.9400187601019574,0.34479281261459477,0.021327313326672426,['SLC2A3'],0.9995549766482514,0,0,1
449,PPAR-alpha pathway WP2878,0.9400187601019574,0.34479281261459477,0.021327313326672426,['CDK4'],0.9995549766482514,0,0,1
450,Amino Acid metabolism WP3925,0.9456351908846167,0.6095900734961625,0.03407512050545702,"['WARS', 'MDH1', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SMS', 'ASS1', 'SRM']",0.9995549766482514,0,0,9
451,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9460200561239209,0.4136096845194424,0.022951825604759172,"['THRA', 'STAT1']",0.9995549766482514,0,0,2
452,Sphingolipid Metabolism (integrated pathway) WP4726,0.9460200561239209,0.4136096845194424,0.022951825604759172,"['ASAH1', 'DEGS2']",0.9995549766482514,0,0,2
453,Male infertility WP4673,0.9463243445040641,0.6436891532620546,0.03551227253059312,"['GNAO1', 'PRMT6', 'CYP26B1', 'MTHFD1', 'UBE2B', 'PARP1', 'MSH5', 'AGO2', 'CAT', 'ERCC2', 'HMGA1', 'MOV10L1']",0.9995549766482514,0,0,12
454,miRNA regulation of prostate cancer signaling pathways WP3981,0.9491253176778682,0.4594495412844037,0.023989899009883374,"['CDKN1B', 'CTNNB1', 'IKBKG']",0.9995549766482514,0,0,3
455,DNA IR-damage and cellular response via ATR WP4016,0.9512500078740809,0.5997045877872558,0.029972252698807645,"['MDC1', 'FEN1', 'PARP1', 'PRKDC', 'RPA1', 'RAD1', 'IKBKG', 'CLSPN', 'TP53BP1']",0.9995549766482514,0,0,9
456,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9516978272433574,0.31824208061831827,0.01575543438812204,['ACOX1'],0.9995549766482514,0,0,1
457,Kennedy pathway from sphingolipids WP3933,0.9516978272433574,0.31824208061831827,0.01575543438812204,['ETNK2'],0.9995549766482514,0,0,1
458,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.9516978272433574,0.31824208061831827,0.01575543438812204,['BCL2L2'],0.9995549766482514,0,0,1
459,Riboflavin and CoQ disorders WP5037,0.9516978272433574,0.31824208061831827,0.01575543438812204,['COQ7'],0.9995549766482514,0,0,1
460,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9516978272433574,0.31824208061831827,0.01575543438812204,['IKBKG'],0.9995549766482514,0,0,1
461,Type II diabetes mellitus WP1584,0.9516978272433574,0.31824208061831827,0.01575543438812204,['PRKCD'],0.9995549766482514,0,0,1
462,Regulation of Actin Cytoskeleton WP51,0.9524646650113022,0.6747687484039384,0.03286276961739738,"['BRK1', 'PIK3C2G', 'ARPC5', 'RHOA', 'ACTG1', 'CDC42', 'PAK1', 'MRAS', 'ABI2', 'TMSB4X', 'CFL1', 'RAC3', 'RAC1', 'PFN1', 'MAPK6', 'FGF22', 'BCAR1']",0.9995549766482514,0,0,17
463,Hematopoietic Stem Cell Differentiation WP2849,0.9548707730644935,0.3938790483177864,0.018189044485555257,"['ZNF835', 'CBFA2T3']",0.9995549766482514,0,0,2
464,MTHFR deficiency WP4288,0.9548707730644935,0.3938790483177864,0.018189044485555257,"['EHMT2', 'CYCS']",0.9995549766482514,0,0,2
465,Signal transduction through IL1R WP4496,0.9548707730644935,0.3938790483177864,0.018189044485555257,"['JUN', 'TOLLIP']",0.9995549766482514,0,0,2
466,Pathways in clear cell renal cell carcinoma WP4018,0.9563446354515021,0.590132927021489,0.026341724255073896,"['PFKL', 'TPI1', 'MDH1', 'PGK1', 'VHL', 'CAMK1', 'ALDOA', 'SQSTM1', 'KCNJ2']",0.9995549766482514,0,0,9
467,BDNF-TrkB Signaling WP3676,0.9566096365322769,0.4430013106159895,0.019651482344869776,"['BDNF', 'ADCY1', 'HRAS']",0.9995549766482514,0,0,3
468,Regulation of toll-like receptor signaling pathway WP1449,0.95894810817419,0.598585916754647,0.025091713559524293,"['OTUD5', 'MAPK9', 'JUN', 'CUEDC2', 'STAT1', 'TOLLIP', 'RAC1', 'IKBKG', 'SQSTM1', 'IFNAR1']",0.9995549766482514,0,0,10
469,Insulin Signaling WP481,0.9593055843246983,0.6876616180273365,0.028569318592740294,"['CAP1', 'EGR1', 'SNAP25', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'STXBP1', 'PRKCD', 'PIK3C2G', 'PTPRF', 'ARHGAP33', 'EHD2', 'MAPK9', 'PFKL', 'SGK3', 'STX4', 'RAC1', 'MAPK6', 'HRAS', 'VAMP2']",0.9995549766482514,0,0,21
470,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9601253759850544,0.5040172693317091,0.02050916985721972,"['SYNGAP1', 'BDNF', 'CAMK4', 'PRKAG1', 'HRAS']",0.9995549766482514,0,0,5
471,Pathways affected in adenoid cystic carcinoma WP3651,0.9606573894371068,0.5275220035330718,0.021173387097445883,"['SMARCE1', 'CEBPA', 'PRKDC', 'NFIB', 'DTX4', 'HRAS']",0.9995549766482514,0,0,6
472,Cholesterol Biosynthesis Pathway WP197,0.961103426795937,0.2954843103357955,0.011722823407192755,['PMVK'],0.9995549766482514,0,0,1
473,Kynurenine Pathway and links to Cellular Senescence WP5044,0.961103426795937,0.2954843103357955,0.011722823407192755,['AFMID'],0.9995549766482514,0,0,1
474,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.961103426795937,0.2954843103357955,0.011722823407192755,['JUN'],0.9995549766482514,0,0,1
475,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.961103426795937,0.2954843103357955,0.011722823407192755,['ACSL3'],0.9995549766482514,0,0,1
476,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.961103426795937,0.2954843103357955,0.011722823407192755,['MDH1'],0.9995549766482514,0,0,1
477,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9619301900729669,0.6351113882432968,0.024650831366492227,"['WNT10B', 'WNT10A', 'SPARC', 'SMAD3', 'JAG1', 'PDCD6', 'NOTCH4', 'DLL3', 'PAK1', 'RBBP4', 'STRAP', 'CTNNB1', 'HRAS', 'MEF2D']",0.9995549766482514,0,0,14
478,Sphingolipid pathway WP1422,0.9623220910059312,0.37594210631628094,0.014438459008510802,"['ASAH1', 'SERINC1']",0.9995549766482514,0,0,2
479,Focal Adhesion WP306,0.9625035267497534,0.6821858756388366,0.026071471905116234,"['PRKCG', 'JUN', 'CAV2', 'TESK2', 'ACTN4', 'PARVB', 'RHOA', 'MYL12B', 'ACTG1', 'PPP1CB', 'CDC42', 'MYL5', 'MAPK9', 'PAK1', 'CCND2', 'RAC3', 'CTNNB1', 'RAC1', 'HRAS', 'PPP1R12C', 'BCAR1']",0.9995549766482514,0,0,21
480,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9630519823488117,0.42768744068332804,0.016101529313673698,"['PAK1', 'JUN', 'HRAS']",0.9995549766482514,0,0,3
481,Vitamin D-sensitive calcium signaling in depression WP4698,0.9630519823488117,0.42768744068332804,0.016101529313673698,"['G6PD', 'CALB1', 'GPX4']",0.9995549766482514,0,0,3
482,Kit receptor signaling pathway WP304,0.9652583909465635,0.49197313886994387,0.017395900021543488,"['STAT1', 'INPP5D', 'RPS6', 'MAPT', 'HRAS']",0.9995549766482514,0,0,5
483,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9652583909465635,0.49197313886994387,0.017395900021543488,"['OTUD5', 'MAPK9', 'PIN1', 'ISG15', 'IKBKG']",0.9995549766482514,0,0,5
484,Rett syndrome causing genes WP4312,0.9652583909465635,0.49197313886994387,0.017395900021543488,"['GNAO1', 'MEF2C', 'SYNGAP1', 'STXBP1', 'RHOBTB2']",0.9995549766482514,0,0,5
485,Neural Crest Differentiation WP2064,0.9654500585863213,0.5164860396767083,0.01816011627052092,"['PAX7', 'NOTCH4', 'HDAC11', 'CTNNB1', 'RHOB', 'DLL3']",0.9995549766482514,0,0,6
486,Apoptosis WP254,0.9662703288310113,0.5355261546000245,0.018374780845793793,"['JUN', 'CYCS', 'BAX', 'IKBKG', 'BCL2L2', 'BBC3', 'BCL2L1']",0.9995549766482514,0,0,7
487,PI3K-Akt signaling pathway WP4172,0.9665891456908263,0.7178742089629343,0.02439462118566715,"['CDKN1B', 'HSP90AB1', 'TGFA', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'CCND2', 'GNG2', 'GNG7', 'RAC1', 'IKBKG', 'HRAS', 'JAK3', 'FGF22', 'EIF4B', 'BDNF', 'RPS6', 'PPP2R5A', 'CREB3', 'CDK4', 'CDC37', 'GNB2', 'GNB1', 'COL9A3', 'SGK3', 'GNB5', 'EIF4E2', 'ATF4', 'IFNAR1', 'BCL2L1']",0.9995549766482514,0,0,31
488,Integrin-mediated Cell Adhesion WP185,0.9669811126207759,0.5816207028780482,0.01952868030992447,"['CDC42', 'PAK1', 'CAPNS1', 'CAV2', 'RAC3', 'ITGAE', 'RAC1', 'MAPK6', 'HRAS', 'BCAR1']",0.9995549766482514,0,0,10
489,Thermogenesis WP4321,0.9675125554951416,0.6041704084198427,0.019953861709397985,"['SMARCE1', 'CREB3', 'SMARCD1', 'SLC25A29', 'RPS6', 'PRKAG1', 'ACSL3', 'ADCY1', 'HRAS', 'ADCY7', 'MGLL', 'ACTG1']",0.9995549766482514,0,0,12
490,Ethanol effects on histone modifications WP3996,0.968583303146032,0.3595648984018629,0.011477594639870824,"['EHMT2', 'ELP3']",0.9995549766482514,0,0,2
491,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9685853975152502,0.413394495412844,0.013194983873510601,"['MAP1LC3A', 'SMAD3', 'FBXO32']",0.9995549766482514,0,0,3
492,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9685853975152502,0.413394495412844,0.013194983873510601,"['MAPK9', 'JUN', 'DDIT3']",0.9995549766482514,0,0,3
493,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9685853975152502,0.413394495412844,0.013194983873510601,"['BDNF', 'AP2A2', 'RHOA']",0.9995549766482514,0,0,3
494,Statin inhibition of cholesterol production WP430,0.9686779833738852,0.2757609094242758,0.008775550677445412,['LPL'],0.9995549766482514,0,0,1
495,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9708012718143892,0.4467992221296186,0.013240222542756213,"['JUN', 'TRAF5', 'BAX', 'BCL2L1']",0.9995549766482514,0,0,4
496,Nanoparticle-mediated activation of receptor signaling WP2643,0.973835264476304,0.34455245781364635,0.009135161564897881,"['MAPK9', 'HRAS']",0.9995549766482514,0,0,2
497,Nuclear receptors WP170,0.973835264476304,0.34455245781364635,0.009135161564897881,"['RXRB', 'THRA']",0.9995549766482514,0,0,2
498,Ebstein-Barr virus LMP1 signaling WP262,0.9747778497891936,0.258502933626696,0.006603633302988432,['IKBKG'],0.9995549766482514,0,0,1
499,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.9747778497891936,0.258502933626696,0.006603633302988432,['SMAD3'],0.9995549766482514,0,0,1
500,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9747778497891936,0.258502933626696,0.006603633302988432,['CTNNB1'],0.9995549766482514,0,0,1
501,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9748954121658002,0.4350027050003864,0.011059980015415007,"['PMVK', 'ACSL3', 'CYP46A1', 'TM7SF2']",0.9995549766482514,0,0,4
502,Energy Metabolism WP1541,0.9748954121658002,0.4350027050003864,0.011059980015415007,"['MEF2C', 'CAMK4', 'PRKAG1', 'MEF2D']",0.9995549766482514,0,0,4
503,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9748954121658002,0.4350027050003864,0.011059980015415007,"['ATG3', 'MAP1LC3A', 'ATG101', 'WIPI2']",0.9995549766482514,0,0,4
504,"GPCRs, Other WP117",0.9773862746927559,0.38748853211009177,0.008863155746158468,"['CCKBR', 'ADGRF5', 'MCHR2']",0.9995549766482514,0,0,3
505,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9782335314683526,0.33074101247248716,0.007278568749743812,"['CDKN1B', 'HRAS']",0.9995549766482514,0,0,2
506,Apoptosis Modulation by HSP70 WP384,0.9796900468993438,0.24327530792294916,0.004991774805635672,['CYCS'],0.9995549766482514,0,0,1
507,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.9796900468993438,0.24327530792294916,0.004991774805635672,['B3GALNT1'],0.9995549766482514,0,0,1
508,miRNAs involvement in the immune response in sepsis WP4329,0.9796900468993438,0.24327530792294916,0.004991774805635672,['IKBKG'],0.9995549766482514,0,0,1
509,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.9796900468993438,0.24327530792294916,0.004991774805635672,['HRAS'],0.9995549766482514,0,0,1
510,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.9796900468993438,0.24327530792294916,0.004991774805635672,['EGR1'],0.9995549766482514,0,0,1
511,TYROBP causal network in microglia WP3945,0.9796900468993438,0.24327530792294916,0.004991774805635672,['ABCC4'],0.9995549766482514,0,0,1
512,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9797042880934962,0.4984158967925078,0.010219768604078947,"['GSK3A', 'RBP4', 'SAR1A', 'MDH1', 'PRKAG1', 'LPL', 'SEC23B']",0.9995549766482514,0,0,7
513,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9819113570322217,0.3179919860037248,0.005804702822393379,"['PDE1B', 'BAX']",0.9995549766482514,0,0,2
514,Hippo-Merlin Signaling Dysregulation WP4541,0.9827537063838421,0.5232661137845832,0.009103126230882589,"['PPP1CB', 'DDB1', 'PAK1', 'PRKAR1A', 'CTNNB1', 'ITGAE', 'CDH9', 'HRAS', 'RBX1']",0.9995549766482514,0,0,9
515,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9836457490778523,0.22973964063072974,0.0037882821204663717,['BCL2L1'],0.9995549766482514,0,0,1
516,Mitochondrial Gene Expression WP391,0.9836457490778523,0.22973964063072974,0.0037882821204663717,['CAMK4'],0.9995549766482514,0,0,1
517,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.984445179546009,0.5004010695187165,0.007844820594488315,"['PRKCG', 'MRAS', 'RPS6', 'TGFA', 'BAX', 'EIF4E2', 'HRAS', 'BCL2L1']",0.9995549766482514,0,0,8
518,"GPCRs, Class A Rhodopsin-like WP455",0.984445179546009,0.5004010695187165,0.007844820594488315,"['MAS1', 'HRH1', 'CCKBR', 'NPY5R', 'GPR22', 'OPRL1', 'SSTR1', 'HTR5A']",0.9995549766482514,0,0,8
519,Head and Neck Squamous Cell Carcinoma WP4674,0.9846023696082681,0.4588537839823659,0.007120219997216853,"['FKBP1A', 'CDK4', 'SESN2', 'RPS6', 'CTNNB1', 'HRAS']",0.9995549766482514,0,0,6
520,Interleukin-11 Signaling Pathway WP2332,0.9863205618074059,0.3541808650065531,0.004878439003126496,"['STAT1', 'RPS6', 'HRAS']",0.9995549766482514,0,0,3
521,EPO Receptor Signaling WP581,0.9868311467922171,0.21762878042190184,0.0028849592344850953,['STAT1'],0.9995549766482514,0,0,1
522,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9868311467922171,0.21762878042190184,0.0028849592344850953,['PRKCG'],0.9995549766482514,0,0,1
523,Vitamin B12 metabolism WP1533,0.9868311467922171,0.21762878042190184,0.0028849592344850953,['SOD1'],0.9995549766482514,0,0,1
524,Bladder cancer WP2828,0.9875436610408681,0.29522586730950634,0.003700529143718324,"['CDK4', 'HRAS']",0.9995549766482514,0,0,2
525,MAPK Cascade WP422,0.9875436610408681,0.29522586730950634,0.003700529143718324,"['JUN', 'HRAS']",0.9995549766482514,0,0,2
526,MECP2 and Associated Rett Syndrome WP3584,0.9883558975840623,0.4423874252125538,0.0051814299241597465,"['GAMT', 'MEF2C', 'BDNF', 'RPS6', 'CAMK2A', 'NREP']",0.9995549766482514,0,0,6
527,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9896401104755338,0.6476820640865585,0.006744913551207266,"['CDKN1B', 'HSP90AB1', 'SLC2A3', 'ITGAE', 'ELAVL1', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'GNG2', 'GNG7', 'IKBKG', 'HRAS', 'JAK3', 'RAB8A', 'FGF22', 'EIF4B', 'RAB2A', 'RPS6', 'PPP2R5A', 'CREB3', 'RAB14', 'CDC37', 'GNB2', 'GNB1', 'EIF4E2', 'ATF4', 'IFNAR1']",0.9995549766482514,0,0,28
528,Cardiac Hypertrophic Response WP2795,0.990132112291739,0.37548391403016956,0.00372363567510013,"['RAC1', 'IKBKG', 'CALM1', 'CALM2']",0.9995549766482514,0,0,4
529,Hedgehog Signaling Pathway WP4249,0.9914519625382328,0.27549523110785035,0.0023650663569182895,"['CCND2', 'ARRB2']",0.9995549766482514,0,0,2
530,Endometrial cancer WP4155,0.991868566582555,0.3970098025367948,0.003241455548854932,"['GADD45B', 'GADD45A', 'CTNNB1', 'BAX', 'HRAS']",0.9995549766482514,0,0,5
531,ESC Pluripotency Pathways WP3931,0.9927888983121282,0.47600927942965454,0.0034449873778320955,"['WNT10B', 'ACTR2', 'WNT10A', 'JUN', 'CTNNB1', 'MAPK6', 'HRAS', 'FGF22', 'SMAD7']",0.9995549766482514,0,0,9
532,Allograft Rejection WP2328,0.9929271863302592,0.2665846212103283,0.0018922028682888054,"['STAT1', 'HLA-DRB1']",0.9995549766482514,0,0,2
533,Ectoderm Differentiation WP2858,0.9930889598602373,0.5154178939617083,0.003574439578006662,"['ABCC4', 'ARHGEF9', 'TSC22D1', 'CCDC88C', 'ST8SIA4', 'PI4KA', 'HMGB2', 'CTNNB1', 'LY6E', 'RGMA', 'SNCA', 'CAP2']",0.9995549766482514,0,0,12
534,Integrated breast cancer pathway WP1984,0.9944338584016651,0.5375086139200949,0.0030002066104635426,"['JUN', 'GSK3A', 'GADD45A', 'STAT1', 'DCAKD', 'ODC1', 'PHB', 'SMAD7', 'CDC42', 'PAK1', 'CDK4', 'CTNNB1', 'BAX', 'RAC1', 'FAU']",0.9995549766482514,0,0,15
535,ErbB signaling pathway WP673,0.995228259640309,0.44,0.0021045910422038297,"['PRKCG', 'MAPK9', 'PAK1', 'JUN', 'CDKN1B', 'CAMK2A', 'TGFA', 'HRAS']",0.9995549766482514,0,0,8
536,Glioblastoma signaling pathways WP2261,0.9954405689477739,0.4185481680328524,0.001912705259141896,"['PRKCG', 'CDKN1B', 'CCND2', 'CDK4', 'PRKCD', 'PIK3C2G', 'HRAS']",0.9995549766482514,0,0,7
537,Resistin as a regulator of inflammation WP4481,0.9955423676775319,0.1722130546387972,0.0007693785589164454,['IKBKG'],0.9995549766482514,0,0,1
538,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9957675716572262,0.39298834890311746,0.0016668248782009617,"['CTNNB1', 'RAC1', 'IKBKG', 'CALM1', 'CALM2', 'RHOA']",0.9995549766482514,0,0,6
539,Glycerophospholipid Biosynthetic Pathway WP2533,0.9964106068836681,0.1653098643197653,0.0005944295490713703,['CDIPT'],0.9995549766482514,0,0,1
540,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9976725409596588,0.1530375259748197,0.00035660372478950433,['SUPT4H1'],0.9995549766482514,0,0,1
541,AMP-activated protein kinase (AMPK) signaling WP1403,0.9980864300067355,0.3056779246206559,0.0005854964772354286,"['PRKAG1', 'ELAVL1', 'SLC2A4RG', 'CAMKK2']",0.9995549766482514,0,0,4
542,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9991539888027217,0.1965726863012263,0.00016637308036182807,"['MAPK9', 'TOLLIP']",0.9995549766482514,0,0,2
543,Phosphoinositides metabolism WP4971,0.9994281075441512,0.18760421530047355,0.00010732012612687031,"['INPP5D', 'PIK3C2G']",0.9995549766482514,0,0,2
544,Mesodermal commitment pathway WP2857,0.9995088481174926,0.362120232708468,0.00017789972545840873,"['ARL4A', 'SMAD3', 'CRTC1', 'PRKAR1A', 'SLC2A12', 'NABP2', 'RPL38', 'HPRT1']",0.9995549766482514,0,0,8
545,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9995549766482514,0.39209502785661726,0.00017453028140716154,"['CAP1', 'MAPK9', 'GSK3A', 'THRA', 'PRKAG1', 'LPL', 'PIK3C2G', 'SLC16A2', 'MAPK6', 'HRAS']",0.9995549766482514,0,0,10
